XNCR


Line plots across dimensions of each concept
Line plots across concepts
Tables

Table of contents



us-gaap:CommonStockValue

us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

us-gaap:WeightedAverageNumberOfSharesOutstandingBasic

us-gaap:EarningsPerShareBasic

us-gaap:EarningsPerShareDiluted

us-gaap:EarningsPerShareBasicAndDiluted

us-gaap:AllocatedShareBasedCompensationExpense
us-gaap:AwardType
us-gaap:IncomeStatementLocation

us-gaap:ComprehensiveIncomeNetOfTax
us-gaap:StatementEquityComponents

us-gaap:GeneralAndAdministrativeExpense

us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest

us-gaap:InterestIncomeExpenseNet

us-gaap:InterestPaidNet

us-gaap:NetIncomeLoss

us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic

us-gaap:NonoperatingIncomeExpense

us-gaap:OperatingExpenses

us-gaap:OperatingIncomeLoss

us-gaap:OtherNonoperatingIncomeExpense
us-gaap:CounterpartyName, us-gaap:TypeOfArrangement

us-gaap:ProfitLoss

us-gaap:ResearchAndDevelopmentExpense

us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
us-gaap:CounterpartyName
us-gaap:CounterpartyName, us-gaap:TypeOfArrangement
us-gaap:ProductOrService

us-gaap:Assets

us-gaap:Liabilities

us-gaap:LiabilitiesAndStockholdersEquity

us-gaap:StockholdersEquity
us-gaap:StatementEquityComponents

us-gaap:AssetsCurrent

us-gaap:CashAndCashEquivalentsAtCarryingValue
us-gaap:CashAndCashEquivalents
us-gaap:CashAndCashEquivalents, us-gaap:FairValueByFairValueHierarchyLevel
us-gaap:FairValueByFairValueHierarchyLevel, us-gaap:FairValueByMeasurementFrequency, us-gaap:InvestmentType
us-gaap:FairValueByMeasurementFrequency, us-gaap:InvestmentType
us-gaap:InvestmentType

us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents

us-gaap:MarketableSecuritiesCurrent

us-gaap:AccountsReceivableNetCurrent
us-gaap:CounterpartyName, us-gaap:ProductOrService, us-gaap:TypeOfArrangement
us-gaap:CounterpartyName, us-gaap:TypeOfArrangement

us-gaap:PrepaidExpenseAndOtherAssetsCurrent

us-gaap:PropertyPlantAndEquipmentGross
us-gaap:PropertyPlantAndEquipmentByType

us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment

us-gaap:PropertyPlantAndEquipmentNet
us-gaap:IndefiniteLivedIntangibleAssetsByMajorClass
us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill

us-gaap:IntangibleAssetsNetExcludingGoodwill

us-gaap:FiniteLivedIntangibleAssetsNet

us-gaap:OperatingLeaseRightOfUseAsset

us-gaap:OtherAssetsNoncurrent

us-gaap:EquitySecuritiesFvNi
us-gaap:CounterpartyName, us-gaap:StatementClassOfStock
us-gaap:FairValueByFairValueHierarchyLevel
us-gaap:FairValueByFairValueHierarchyLevel, us-gaap:FairValueByMeasurementFrequency
us-gaap:FairValueByMeasurementFrequency
us-gaap:StatementClassOfStock

us-gaap:AccountsPayableCurrent

us-gaap:AccruedLiabilitiesCurrent

us-gaap:ContractWithCustomerLiabilityCurrent

us-gaap:LiabilitiesCurrent

us-gaap:OperatingLeaseLiabilityCurrent

us-gaap:OperatingLeaseLiabilityNoncurrent

us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo

us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree

us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour

us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive

us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive

us-gaap:OperatingLeaseLiability

us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue

us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount

us-gaap:StockholdersEquity
us-gaap:StatementEquityComponents

us-gaap:CommonStockValue

us-gaap:AdditionalPaidInCapital

us-gaap:RetainedEarningsAccumulatedDeficit

us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax

us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
us-gaap:StatementEquityComponents

us-gaap:NetCashProvidedByUsedInOperatingActivities

us-gaap:NetCashProvidedByUsedInInvestingActivities

us-gaap:NetCashProvidedByUsedInFinancingActivities

us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect

us-gaap:DepreciationDepletionAndAmortization

us-gaap:IncreaseDecreaseInAccountsPayable

us-gaap:NetCashProvidedByUsedInOperatingActivities

us-gaap:NetIncomeLoss

us-gaap:ProfitLoss

us-gaap:ShareBasedCompensation
us-gaap:AwardType
us-gaap:IncomeStatementLocation

us-gaap:NetCashProvidedByUsedInInvestingActivities

us-gaap:PaymentsToAcquirePropertyPlantAndEquipment

us-gaap:NetCashProvidedByUsedInFinancingActivities
us-gaap:AwardType
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
us-gaap:AwardType
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice

us-gaap:DeferredTaxAssetsNet

us-gaap:DeferredTaxAssetsValuationAllowance

us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments
us-gaap:CounterpartyName, us-gaap:ProductOrService, us-gaap:TypeOfArrangement
us-gaap:ContractWithCustomerLiabilityRevenueRecognized
us-gaap:CounterpartyName, us-gaap:TypeOfArrangement

us-gaap:DebtSecuritiesAvailableForSaleUnrealizedGainLoss

us-gaap:EquitySecuritiesFvNiGainLoss

us-gaap:EquitySecuritiesFvNiRealizedGainLoss
us-gaap:CounterpartyName, us-gaap:SubsequentEventType
us-gaap:CounterpartyName, us-gaap:TypeOfArrangement

us-gaap:EquitySecuritiesFvNiUnrealizedGainLoss
us-gaap:CounterpartyName, us-gaap:IncomeStatementLocation, us-gaap:TypeOfArrangement
us-gaap:CounterpartyName, us-gaap:TypeOfArrangement

us-gaap:GainLossOnDispositionOfAssets1

us-gaap:IncomeLossFromEquityMethodInvestments

us-gaap:IncreaseDecreaseInAccountsAndOtherReceivables

us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable

us-gaap:IncreaseDecreaseInAccruedInvestmentIncomeReceivable

us-gaap:IncreaseDecreaseInAccruedLiabilities

us-gaap:IncreaseDecreaseInContractWithCustomerAsset

us-gaap:IncreaseDecreaseInContractWithCustomerLiability

us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets

us-gaap:LeaseCost

us-gaap:MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments

us-gaap:MarketableSecuritiesUnrealizedGainLoss

us-gaap:NoncashProjectAbandonmentCosts

us-gaap:OperatingLeaseCost

us-gaap:OperatingLeasePayments

us-gaap:PaymentsToAcquireIntangibleAssets

us-gaap:PaymentsToAcquireMarketableSecurities

us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions

us-gaap:ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities

us-gaap:ProceedsFromStockPlans

us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
us-gaap:AwardType
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
us-gaap:AwardType
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
us-gaap:AwardType
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
us-gaap:AwardType
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
us-gaap:AwardType
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
us-gaap:AwardType
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
us-gaap:AwardType
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
us-gaap:AwardType
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
us-gaap:AwardType
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
us-gaap:AwardType
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
us-gaap:AwardType
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
us-gaap:AwardType
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
us-gaap:AwardType
us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
us-gaap:AwardType
us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
us-gaap:AwardType
us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
us-gaap:AwardType
us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised

us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
us-gaap:StatementEquityComponents
us-gaap:StatementEquityComponents
us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures

us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
us-gaap:StatementEquityComponents

us-gaap:VariableLeaseCost
us-gaap:CounterpartyName, us-gaap:TypeOfArrangement
xncr:CashConsiderationOnSaleOfOption
us-gaap:CounterpartyName, us-gaap:TypeOfArrangement
xncr:CollaborativeArrangementNonrefundableUpfrontFees
us-gaap:CounterpartyName, us-gaap:TypeOfArrangement
xncr:CollaborativeArrangementPercentageEquityPrivateCompany
us-gaap:CounterpartyName, us-gaap:TypeOfArrangement
xncr:ConsiderationOnSaleOfOption
us-gaap:CounterpartyName, us-gaap:TypeOfArrangement
xncr:ConsiderationOnSaleOfOptionEquityIssuedValue

xncr:IncreaseDecreaseInLeaseLiabilitiesAndRightOfUseAssets
us-gaap:CounterpartyName, us-gaap:TypeOfArrangement
xncr:NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationShareValue
us-gaap:StatementScenario, us-gaap:PropertyPlantAndEquipmentByType
xncr:RentExpensePerSquareFoot
us-gaap:PlanName
xncr:ShareBasedCompensationArrangementByShareBasedPaymentAwardAnnualPercentageIncreaseInSharesAuthorized
us-gaap:Range, us-gaap:AwardType
us-gaap:IncomeTaxAuthority
xncr:TaxRefundReceived

us-gaap:AssetsFairValueDisclosure
us-gaap:FairValueByFairValueHierarchyLevel
us-gaap:FairValueByFairValueHierarchyLevel, us-gaap:FairValueByMeasurementFrequency
us-gaap:FairValueByMeasurementFrequency

us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
us-gaap:InvestmentType

us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
us-gaap:InvestmentType

us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
us-gaap:InvestmentType

us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost

us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue

us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost

us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue

us-gaap:AvailableForSaleSecuritiesDebtSecurities
us-gaap:BalanceSheetLocation
us-gaap:FairValueByFairValueHierarchyLevel, us-gaap:FairValueByMeasurementFrequency, us-gaap:InvestmentType
us-gaap:FairValueByFairValueHierarchyLevel, us-gaap:InvestmentType
us-gaap:FairValueByMeasurementFrequency, us-gaap:InvestmentType
us-gaap:InvestmentType

us-gaap:CashUninsuredAmount
us-gaap:CounterpartyName, us-gaap:ProductOrService, us-gaap:TypeOfArrangement
us-gaap:ContractWithCustomerAssetNet
us-gaap:CounterpartyName, us-gaap:TypeOfArrangement
us-gaap:CounterpartyName, us-gaap:TypeOfArrangement, xncr:PotentialMilestonesType

us-gaap:ContractWithCustomerAssetNetCurrent

us-gaap:ContractWithCustomerLiability
us-gaap:CounterpartyName, us-gaap:ProductOrService, us-gaap:TypeOfArrangement
us-gaap:CounterpartyName, us-gaap:TypeOfArrangement

us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
us-gaap:InvestmentType

us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
us-gaap:InvestmentType

us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
us-gaap:InvestmentType

us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
us-gaap:InvestmentType

us-gaap:DebtSecuritiesCurrent

us-gaap:DebtSecuritiesNoncurrent

us-gaap:DeferredIncomeTaxLiabilities

us-gaap:DeferredTaxAssetsDeferredIncome

us-gaap:DeferredTaxAssetsGross

us-gaap:DeferredTaxAssetsOperatingLossCarryforwards

us-gaap:DeferredTaxAssetsPropertyPlantAndEquipment

us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch

us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation

us-gaap:DeferredTaxAssetsUnrealizedLossesOnAvailableforSaleSecuritiesGross

us-gaap:DeferredTaxLiabilitiesDeferredExpenseCapitalizedPatentCosts

us-gaap:DeferredTaxLiabilitiesOtherComprehensiveIncome
us-gaap:AwardType
us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions
us-gaap:AwardType
us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions

us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
us-gaap:CounterpartyName, us-gaap:StatementClassOfStock
us-gaap:FairValueByFairValueHierarchyLevel
us-gaap:FairValueByFairValueHierarchyLevel, us-gaap:FairValueByMeasurementFrequency
us-gaap:FairValueByMeasurementFrequency
us-gaap:StatementClassOfStock
us-gaap:FairValueByAssetClass, us-gaap:FairValueByFairValueHierarchyLevel
us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
us-gaap:FiniteLivedIntangibleAssetsByMajorClass
us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization

us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive

us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths

us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive

us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour

us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree

us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
us-gaap:FiniteLivedIntangibleAssetsByMajorClass
us-gaap:FiniteLivedIntangibleAssetsGross

us-gaap:IntangibleAssetsGrossExcludingGoodwill

us-gaap:InterestReceivableCurrent

us-gaap:Investments

us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths

us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear

us-gaap:MarketableSecuritiesNoncurrent

us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent
us-gaap:IncomeTaxAuthority
us-gaap:OperatingLossCarryforwards
us-gaap:IncomeTaxAuthority, us-gaap:TaxPeriod
us-gaap:CounterpartyName
us-gaap:OtherCommitment
us-gaap:CounterpartyName, us-gaap:TypeOfArrangement
us-gaap:CounterpartyName, us-gaap:ProductOrService, us-gaap:TypeOfArrangement
us-gaap:RevenueRemainingPerformanceObligation
us-gaap:CounterpartyName, us-gaap:TypeOfArrangement
us-gaap:CounterpartyName, us-gaap:TypeOfArrangement, xncr:CollaborationAndLicensingPrograms
us-gaap:AwardType
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
us-gaap:AwardType
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
us-gaap:AwardType
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
us-gaap:AwardType
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
us-gaap:AwardType
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
us-gaap:AwardType
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
us-gaap:AwardType
us-gaap:SharePrice
us-gaap:AwardType
us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1

us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1
us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRange

us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1
us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRange
us-gaap:IncomeTaxAuthority
us-gaap:TaxCreditCarryforwardAmount
us-gaap:CounterpartyName, us-gaap:TypeOfArrangement
xncr:AnnualFundingAmount

xncr:CashAndCashEquivalentsAndMarketableSecuritiesAmortizedCost
us-gaap:CounterpartyName, us-gaap:ProductOrService, us-gaap:TypeOfArrangement
xncr:CollaborativeArrangementReceivablePayableRelatedToCostSharingDevelopmentActivities
us-gaap:CounterpartyName, us-gaap:TypeOfArrangement

xncr:DeferredTaxLiabilitiesCapitalizedLegalCosts

xncr:DeferredTaxLiabilitiesEquityInvestment

xncr:DeferredTaxLiabilitiesLicenseCosts

xncr:EquitySecuritiesCurrent

xncr:EquitySecuritiesNoncurrent
us-gaap:CounterpartyName, us-gaap:TypeOfArrangement
xncr:PercentageOfCoDetailingActivities
us-gaap:CounterpartyName, us-gaap:TypeOfArrangement
xncr:PercentageOfFundingForDevelopmentCosts
us-gaap:Range, us-gaap:AwardType
xncr:ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfCompensationWithheldToPurchaseSharesAtDiscount

Plots across concepts


IncomeStatement
Income Loss From Continuing Operations 
Before Income Taxes Extraordinary Items Noncontrolling Interest
Balance Sheet
Operating Lease Liability
Assets
Operating Lease Right Of Use Asset
Current Assets
Accounts Receivable Net Current
NonCurrent Assets
Other Assets Noncurrent
PropertyPlantAndEquipmentNet
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
Liabilities
Operating Lease Liability
Current Liabilities
Operating Lease Liability Current
Stockholders Equity
Retained Earnings Accumulated Deficit
CashFlow
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInOperatingActivities
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInInvestingActivities
Net Cash Provided By Used In Investing Activities
Shares
Weighted Average Number Of Diluted Shares Outstanding
OperatingLeaseLiability
Operating Lease Liability Current
NonoperatingIncomeExpense
Other Nonoperating Income Expense
LesseeOperatingLeaseLiabilityPaymentsDue
Lessee Operating Lease Liability Undiscounted Excess Amount

Tables

  2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302017-12-312017-09-302017-06-302017-03-31
us-gaap:CommonStockValue ███▇▇▇▇▇▇▇▇▇▁▁▁▁0.5840.5830.580.5730.5720.570.5690.5670.5650.5640.5630.5620.470.470.4680.467
us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding NANANA57.26611257.0596156.946714NA56.64307556.39925558.009878NA58.313002NA46.92949846.767759NA
us-gaap:WeightedAverageNumberOfSharesOutstandingBasic NANANA57.26611257.0596156.946714NA56.64307556.39925556.302967NA55.97408NA46.92949846.767759NA
us-gaap:EarningsPerShareBasic 0.9NA-0.24-0.22-0.61-0.14-0.47-0.18-0.281.42-0.320.06-0.25-0.33-0.15-0.31
us-gaap:EarningsPerShareDiluted 0.87NA-0.24-0.22-0.61-0.14-0.47-0.18-0.281.38-0.320.05-0.25-0.33-0.15-0.31
us-gaap:EarningsPerShareBasicAndDiluted NA-0.04NANANA-0.14NANANANANANA0.16000000000000003-0.48-0.17-0.31
  2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302017-12-312017-09-302017-06-302017-03-31
  2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302017-12-312017-09-302017-06-302017-03-31
 TTM Greenblatt ROC _ _▄▂▂▂▁▃▁▂▂█▂▃▂▂▃▂9.087-15.672-13.698-16.722-37.6-8.777-30.572-14.276-19.57278.244-21.0820.651-13.882-16.49-7.67-15.519
  2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302017-12-312017-09-302017-06-302017-03-31
us-gaap:AllocatedShareBasedCompensationExpense NANA8.5398.3188.2316.5127.2279.5149.3035.8565.0756.123.443.6053.4483.158
 us-gaap:AllocatedShareBasedCompensationExpense us-gaap:AwardType us-gaap:EmployeeStockNANA0.1840.2090.2130.1940.0570.2170.1950.2170.1820.2090.1070.1430.1290.119
 us-gaap:AllocatedShareBasedCompensationExpense us-gaap:AwardType us-gaap:EmployeeStockOptionNANA6.8736.6246.6675.8826.9149.1178.9465.5254.8145.8323.3333.4623.3193.039
 us-gaap:AllocatedShareBasedCompensationExpense us-gaap:AwardType us-gaap:RestrictedStockUnitsRSUNANA1.4971.4851.3510.4360.2070.180.1620.1140.0790.079NANANANA
 us-gaap:AllocatedShareBasedCompensationExpense us-gaap:IncomeStatementLocation us-gaap:GeneralAndAdministrativeExpenseNANA2.7942.8812.8042.2912.5172.4742.0081.8541.6622.7321.3121.4221.4161.467
 us-gaap:AllocatedShareBasedCompensationExpense us-gaap:IncomeStatementLocation us-gaap:ResearchAndDevelopmentExpenseNANA5.7645.4375.4274.2214.6617.047.2954.0023.4133.3882.1282.1832.0321.691
us-gaap:ComprehensiveIncomeNetOfTax ▆▃▂▂▁▃▁▂▂█▂▃▂▂▃▂52.136-2.464-14.184-13.466-34.591-8.179-27.187-10.417-14.7581.361-16.8322.82-12.554-15.419-6.929-14.39
us-gaap:GeneralAndAdministrativeExpense █▇▆▆▆▆▅▄▃▃▃▆▁▁▁▂8.8638.2267.6037.6367.2317.2196.7496.2665.7585.5125.5177.4354.4274.1724.0914.811
us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest NANA-13.691-12.55-35.018-8.074-27.2-10.574-15.98480.945-18.1993.15-12.929-15.389-6.605-14.465
us-gaap:InterestIncomeExpenseNet ▁▁▂▄▅▇▇██▆▆▆▃▃0.1470.2150.7121.4232.093.0393.4183.6993.6152.8862.8072.6421.0471.045NANA
us-gaap:InterestPaidNet ▆▅▁▅▆▇▁▅▄▅█▄▆▄▃▄0.0050.0040.00.0040.0050.0060.00.0040.0030.0040.0070.0030.0050.0030.0020.003
us-gaap:NetIncomeLoss ▆▃▂▂▁▃▁▃▂█▂▃▂▂▃▂52.248-2.487-13.691-12.55-35.018-8.074-26.912-10.224-16.03480.045-18.1973.15-11.843-15.562-6.885-14.635
us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic ▆▃▂▂▁▃▁▃▂█▂▃▃▂▃▂52.248-2.487-13.691-12.55-35.018-8.074-26.912-10.224-16.03480.045-18.1993.15-3.072-22.652-7.725-15.475
us-gaap:NonoperatingIncomeExpense █▃▁▂▁▁▂▂▂▁▁▁▁▁▁▁43.16113.1850.0074.1722.5820.7033.3733.7023.5882.7012.8842.4990.9541.1011.0651.054
us-gaap:OperatingExpenses █▆▇▇▇▅▄▄▄▄▃▃▂▂▁▁58.3649.63755.55252.08850.68941.16234.08936.03639.05733.69532.64728.38824.82323.5821.0119.859
us-gaap:OperatingIncomeLoss ▄▂▂▂▁▃▁▂▂█▂▃▂▂▃▂9.087-15.672-13.698-16.722-37.6-8.777-30.572-14.276-19.57278.244-21.0820.651-13.882-16.49-7.67-15.519
us-gaap:OtherNonoperatingIncomeExpense ▂█▂▃▂▁▂▂▂▂▂▂▂▂▂-0.00612.97-0.7052.7490.492-2.336-0.0450.003-0.027-0.1850.077-0.143-0.0930.0560.03NA
 us-gaap:OtherNonoperatingIncomeExpense us-gaap:CounterpartyName,us-gaap:TypeOfArrangement xncr:CatabsisPharmaceuticalsInc,xncr:TechnologyLicenseAgreementNA12.9NANANANANANANANANANANANANANA
 us-gaap:OtherNonoperatingIncomeExpense us-gaap:CounterpartyName,us-gaap:TypeOfArrangement xncr:MiragenViridian,xncr:TechnologyLicenseAgreementNA0.1NANANANANANANANANANANANANANA
us-gaap:ProfitLoss ▆▃▂▂▁▃▁▃▂█▂▃▂▂▃▂52.248-2.487-13.691-12.55-35.018-8.074-26.912-10.225-16.03380.045-18.1993.151-11.843-15.563-6.044-15.475
us-gaap:ResearchAndDevelopmentExpense █▆█▇▇▅▃▄▅▄▃▂▂▂▁▁49.49741.41147.94944.45243.45833.94327.3429.7733.29928.18327.1320.95320.39619.40816.91915.048
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax ▅▃▄▃▂▃▁▂▂█▂▃▃▁▂▁67.44733.96541.85435.36613.08932.3853.51621.7619.485111.93911.56429.03930.150.012.53.5
  2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302017-12-312017-09-302017-06-302017-03-31
  2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302017-12-312017-09-302017-06-302017-03-31
us-gaap:Assets ███▇▇▇▇███▅▅▁▁▂▂695.602692.737703.244646.349644.72666.963670.25686.244684.753697.003576.732585.586390.102398.255416.164418.303
us-gaap:Liabilities ▁▆█▃▃▃▃▃▃▄▂▁▆▆▇▇48.664109.125130.877.86674.07573.95877.04976.00776.66287.43855.05153.313108.056107.716114.799114.555
us-gaap:LiabilitiesAndStockholdersEquity ███▇▇▇▇███▅▅▁▁▂▂695.602692.737703.244646.349644.72666.963670.25686.244684.753697.003576.732585.586390.102398.255416.164418.303
us-gaap:StockholdersEquity █▇▇▆▇▇▇▇▇▇▆▆▁▁▁▁646.938583.612572.444568.483570.645593.005593.201610.237608.091609.565521.681532.273282.046290.539301.365303.748
  2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302017-12-312017-09-302017-06-302017-03-31
us-gaap:AssetsCurrent ▆▇█▇▇▇▇▇▆▆▃▃▂▂▂▁480.967591.168637.672570.883603.386588.107558.405573.765527.009488.671315.727286.92230.879217.81210.982166.089
us-gaap:CashAndCashEquivalentsAtCarryingValue ▅█▇▃▅▄▃▃▂▁▂▂▁▁▁▁115.842176.965163.54458.094109.53473.80850.31251.18932.55721.85826.24634.99616.52813.63411.2213.561
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents ▅█▇▃▅▄▃▃▂▁▂▂▁▁▁115.842176.965163.54458.094109.53473.80850.31251.18932.55721.85826.24634.99616.52813.63411.22NA
us-gaap:MarketableSecuritiesCurrent NANANA487.688474.114497.841479.47495.292472.613318.498268.115236.605207.603196.318177.269141.225
us-gaap:AccountsReceivableNetCurrent ▂▂▂▁▁▁▂▁▁█▁▁▁▁▂▁14.82512.52511.4439.5348.9256.82521.5744.34910.13137.67610.1872.4621.1420.83114.8766.938
us-gaap:PrepaidExpenseAndOtherAssetsCurrent █▇▅▅▃▂▂▃▅▄▅▆▂▃▃▁15.59414.16410.72610.1857.3986.4766.5477.53311.3079.43310.37512.0955.6067.0277.6174.365
  2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302017-12-312017-09-302017-06-302017-03-31
us-gaap:PropertyPlantAndEquipmentGross NANA38.713NANANA28.41NANANA21.239NA15.036NANANA
 us-gaap:PropertyPlantAndEquipmentGross us-gaap:PropertyPlantAndEquipmentByType us-gaap:FurnitureAndFixturesNANA0.527NANANA0.492NANANA0.173NA0.152NANANA
 us-gaap:PropertyPlantAndEquipmentGross us-gaap:PropertyPlantAndEquipmentByType us-gaap:LeaseholdsAndLeaseholdImprovementsNANA6.957NANANA6.831NANANA4.774NA4.01NANANA
 us-gaap:PropertyPlantAndEquipmentGross us-gaap:PropertyPlantAndEquipmentByType xncr:ComputersSoftwareAndEquipmentNANA31.229NANANA21.087NANANA16.292NA10.874NANANA
us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment NANA17.031NANANA12.605NANANA9.426NA7.948NANANA
us-gaap:PropertyPlantAndEquipmentNet ██▇▇▆▆▅▅▄▄▄▃▂▂▁▁23.13222.30121.68219.77116.23916.79915.80513.86812.12811.45611.8139.6887.0886.0853.8613.36
 us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill us-gaap:IndefiniteLivedIntangibleAssetsByMajorClass us-gaap:TrademarksNANA0.399NANANA0.399NANANA0.399NA0.399NANANA
us-gaap:IntangibleAssetsNetExcludingGoodwill █▇▇▇▆▆▆▅▄▃▂▂▁▁▁▁16.38415.5515.97715.31915.16214.63714.42114.02713.52212.73711.96911.67711.14811.04310.86510.886
us-gaap:FiniteLivedIntangibleAssetsNet NANA7.146NANANANANANANANANANANANANA
us-gaap:OperatingLeaseRightOfUseAsset NANA10.6NANANA9.38NANANANANANANANANA
us-gaap:OtherAssetsNoncurrent ▄▇▁▆▆▇▁▇██▁▁▁▁▁▁4.35410.4170.2128.6088.7889.1880.31110.18710.72611.2650.3110.3110.2650.2650.2140.103
us-gaap:EquitySecuritiesFvNi █▂▁▂▁▁45.236.1365.3035.3822.6112.253NANANANANANANANANANA
  2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302017-12-312017-09-302017-06-302017-03-31
us-gaap:AccountsPayableCurrent ▃▄▅█▆▆▆▄▅▂▁▃▃▃▄▁7.1127.6638.95413.10910.51310.31310.1898.3048.9945.4853.7975.9836.8696.6027.3794.275
us-gaap:AccruedLiabilitiesCurrent █▅█▅▄▃▄▃▂▂▄▂▂▁▁▂17.32812.51317.60311.3819.1577.2928.9957.8326.2265.7059.6625.6715.484.6363.9846.502
us-gaap:ContractWithCustomerLiabilityCurrent ▁▇█▃▃▄▃▄▄▅▃▃▅19.277.82192.61543.8444.68546.17645.20545.57945.47859.24440.07940.07960.118NANANA
us-gaap:LiabilitiesCurrent ▁▆█▃▃▃▃▃▃▄▂▂▆▆▇▇45.96299.931121.06170.48866.44965.91766.55864.31263.71273.32153.85352.027101.345100.326107.431106.875
us-gaap:OperatingLeaseLiabilityCurrent █▂▁▅▄▅▆▆▆▃2.3221.9341.8892.1582.0942.1362.1692.1972.2141.987NANANANANANA
  2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302017-12-312017-09-302017-06-302017-03-31
us-gaap:OperatingLeaseLiabilityNoncurrent ▁▇█▅▆▆▆▇▇█2.7029.1949.7397.3787.6268.0418.5659.0829.6510.221NANANANANANA
us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo ▁▄██0.7071.4152.2692.269NANANANANANANANANANANANA
us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree ▁███0.7291.4361.4151.415NANANANANANANANANANANANA
us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour ▁███0.6881.3961.4361.436NANANANANANANANANANANANA
us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive NA1.481.3961.33NANANANANANANANANANANANA
us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive NA3.8615.3421.238NANANANANANANANANANANANA
  2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302017-12-312017-09-302017-06-302017-03-31
us-gaap:StockholdersEquity █▇▇▆▇▇▇▇▇▇▆▆▁▁▁▁646.938583.612572.444568.483570.645593.005593.201610.237608.091609.565521.681532.273282.046290.539301.365303.748
us-gaap:CommonStockValue ███▇▇▇▇▇▇▇▇▇▁▁▁▁0.5840.5830.580.5730.5720.570.5690.5670.5650.5640.5630.5620.470.470.4680.467
us-gaap:AdditionalPaidInCapital ███▇▇▇▇▇▆▆▆▆▁▁▁▁962.343951.154937.525919.387908.084895.855887.873877.724865.163851.888845.366839.127570.67566.609562.017557.473
us-gaap:RetainedEarningsAccumulatedDeficit ▄▁▁▂▃▅▅▇▇█▄▅▆▆▇▇-315.974-368.222-365.735-352.044-339.494-304.476-296.402-269.49-259.266-243.232-323.277-305.078-287.286-275.443-259.88-252.996
us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax ▅▅▅▆█▇▇██▆▃▁▂▃▃▃-0.0150.0970.0740.5671.4831.0561.1611.4361.6290.345-0.971-2.338-1.808-1.097-1.24-1.196
us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue █▁9.358.293NA8.3188.2316.512NA9.5149.3035.8565.0756.123.443.6043.4493.158
  2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302017-12-312017-09-302017-06-302017-03-31
us-gaap:NetCashProvidedByUsedInOperatingActivities ▂▁▃▂▁▃▂▂█▂▂▂▂▂▂▂-9.654-29.96617.084-3.866-27.6829.46-19.577-6.477109.156-18.728-16.781-10.311-6.666-3.509-12.962-10.546
us-gaap:NetCashProvidedByUsedInInvestingActivities ▃▆█▃▇▅▆▆▁▅▅▅▅▅▅▅-53.30938.04878.779-50.5659.40812.56515.72722.06-102.4313.6736.8665.8628.9394.9339.5258.553
us-gaap:NetCashProvidedByUsedInFinancingActivities ▂▅█▃▄▂▃▃▄▁▁▄▁▁▁▁1.845.3399.5872.9864.01.4712.9733.0493.9730.6671.1654.1530.6210.991.0961.026
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect ▁▄█▁▅▅▄▄▄▃▃▄▄▄-61.12313.421105.45-51.4435.72623.496-0.87718.63210.699-4.388-8.75-0.2962.8942.414NANA
  2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302017-12-312017-09-302017-06-302017-03-31
us-gaap:DepreciationDepletionAndAmortization █▇▇▆▆▆▅▄▄▄▃▃▂▂▁▁1.7531.6381.5321.4461.4431.3731.2251.071.0070.9960.8830.8160.610.5560.4540.41
us-gaap:IncreaseDecreaseInAccountsPayable ▄▄▁▇▅▅▇▄█▆▃▆▅▄█▅-0.551-1.291-4.1552.5960.20.1241.884-0.6893.5081.689-2.1861.0670.267-0.7783.1050.395
us-gaap:NetCashProvidedByUsedInOperatingActivities ▂▁▃▂▁▃▂▂█▂▂▂▂▂▂▂-9.654-29.96617.084-3.866-27.6829.46-19.577-6.477109.156-18.728-16.781-10.311-6.666-3.509-12.962-10.546
us-gaap:NetIncomeLoss ▆▃▂▂▁▃▁▃▂█▂▃▂▂▃▂52.248-2.487-13.691-12.55-35.018-8.074-26.912-10.224-16.03480.045-18.1973.15-11.843-15.562-6.885-14.635
us-gaap:ProfitLoss ▆▃▂▂▁▃▁▃▂█▂▃▂▂▃▂52.248-2.487-13.691-12.55-35.018-8.074-26.912-10.225-16.03380.045-18.1993.151-11.843-15.563-6.044-15.475
us-gaap:ShareBasedCompensation █▇▇▇▇▅▅██▄▃▄▁▁▁▁9.358.2938.5588.3188.2316.5127.1789.5149.3035.8565.0756.123.443.6043.4493.158
  2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302017-12-312017-09-302017-06-302017-03-31
us-gaap:NetCashProvidedByUsedInInvestingActivities ▃▆█▃▇▅▆▆▁▅▅▅▅▅▅▅-53.30938.04878.779-50.5659.40812.56515.72722.06-102.4313.6736.8665.8628.9394.9339.5258.553
us-gaap:PaymentsToAcquirePropertyPlantAndEquipment ▄▄▅█▁▄▅▅▃▁▅▂▃▅▂▁2.2831.9513.1494.6950.6222.0732.912.5761.4520.4152.7871.0091.4772.5780.7620.494
  2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302017-12-312017-09-302017-06-302017-03-31
us-gaap:NetCashProvidedByUsedInFinancingActivities ▂▅█▃▄▂▃▃▄▁▁▄▁▁▁▁1.845.3399.5872.9864.01.4712.9733.0493.9730.6671.1654.1530.6210.991.0961.026
  2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302017-12-312017-09-302017-06-302017-03-31

Common Stock Value

us-gaap:CommonStockValue

us-gaap:CommonStockValue


Common
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-31
Value584000.0583000.0580000.0573000.0572000.0570000.0569000.0567000.0565000.0564000.0563000.0562000.0558000.0556000.0470000.0470000.0468000.0467000.0466000.0411000.0409000.0407000.0405000.0405000.0405000.0404000.0314000.0314000.0314000.0314000.0314000.0
Percentage of CommonStockValue100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets0.10.10.10.10.10.10.10.10.10.10.10.10.10.10.10.10.10.10.10.10.10.20.20.20.20.20.50.40.40.40.4

Weighted Average Number Of Diluted Shares Outstanding

us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding


Weighted
Period End2020-09-302020-06-302020-03-312019-09-302019-06-302019-03-312018-09-302018-06-302018-03-312017-09-302017-06-302016-09-302016-06-302015-09-302015-06-302014-09-302014-06-302013-09-302013-06-30
Value57575656565858554746464141404031310.07230212
Percentage of WeightedAverageNumberOfDilutedSharesOutstanding100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

Weighted Average Number Of Shares Outstanding Basic

us-gaap:WeightedAverageNumberOfSharesOutstandingBasic

us-gaap:WeightedAverageNumberOfSharesOutstandingBasic


Weighted
Period End2020-09-302020-06-302020-03-312019-09-302019-06-302019-03-312018-09-302018-06-302018-03-312017-09-302017-06-302016-09-302016-06-302015-09-302015-06-302014-09-302014-06-302013-09-302013-06-30
Value57575656565655554746464140404031310.0723020.072302
Percentage of WeightedAverageNumberOfSharesOutstandingBasic100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

Earnings Per Share Basic

us-gaap:EarningsPerShareBasic

us-gaap:EarningsPerShareBasic


Earnings
Period End2021-06-302020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-31
Value0.9-0.24-0.22-0.61-0.14-0.47-0.18-0.281.42-0.320.06-0.46-0.62-0.25-0.33-0.15-0.31-0.21-0.21.16-0.160.19-0.25-0.22-0.19-0.04-0.2-0.16-0.12-0.37-57.871341.7-63.78
Percentage of EarningsPerShareBasic100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

Earnings Per Share Diluted

us-gaap:EarningsPerShareDiluted

us-gaap:EarningsPerShareDiluted


Earnings
Period End2021-06-302020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-31
Value0.87-0.24-0.22-0.61-0.14-0.47-0.18-0.281.38-0.320.05-0.46-0.62-0.25-0.33-0.15-0.31-0.21-0.21.13-0.160.19-0.25-0.22-0.19-0.04-0.2-0.16-0.12-0.37-57.87-3.88-63.78
Percentage of EarningsPerShareDiluted100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

Earnings Per Share Basic And Diluted

us-gaap:EarningsPerShareBasicAndDiluted

us-gaap:EarningsPerShareBasicAndDiluted


Earnings
Period End2021-03-312020-03-312018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-03-31
Value-0.04-0.14-0.46-0.620.16-0.48-0.17-0.31-0.16
Percentage of EarningsPerShareBasicAndDiluted100.0100.0100.0100.0100.0100.0100.0100.0100.0

Allocated Share Based Compensation Expense

us-gaap:AllocatedShareBasedCompensationExpense

us-gaap:AllocatedShareBasedCompensationExpense


Allocated
Period End2020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-31
Value8.5398.3188.2316.5127.2279.5149.3035.8565.0756.124.8824.4713.443.6053.4483.1581.991.8662.0331.961.4831.0861.1931.1070.7510.4910.3610.2780.1440.0440.0050.005
Percentage of AllocatedShareBasedCompensationExpense100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax20.423.562.920.1205.543.747.75.243.921.10.00.011.40.027.690.20.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0

us-gaap:AllocatedShareBasedCompensationExpense us-gaap:AwardType

us-gaap:EmployeeStock


Allocated
Period End2020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-31
Value0.1840.2090.2130.1940.0570.2170.1950.2170.1820.2090.190.1630.1070.1430.1290.119
Percentage of AllocatedShareBasedCompensationExpense2.22.52.63.00.82.32.13.73.63.43.93.63.14.03.73.8
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.40.61.60.61.61.01.00.21.60.70.00.00.40.01.03.4
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax us-gaap:EmployeeStock0.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0

us-gaap:EmployeeStockOption


Allocated
Period End2020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-31
Value6.8736.6246.6675.8826.9149.1178.9465.5254.8145.8324.6144.2763.3333.4623.3193.039
Percentage of AllocatedShareBasedCompensationExpense80.579.681.090.395.795.896.294.394.995.394.595.696.996.096.396.2
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax16.418.750.918.2196.641.945.94.941.620.10.00.011.10.026.686.8
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax us-gaap:EmployeeStockOption0.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0

us-gaap:RestrictedStockUnitsRSU


Allocated
Period End2020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-31
Value1.4971.4851.3510.4360.2070.180.1620.1140.0790.0790.0780.032
Percentage of AllocatedShareBasedCompensationExpense17.517.916.46.72.91.91.71.91.61.31.60.7
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax3.64.210.31.35.90.80.80.10.70.30.00.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax us-gaap:RestrictedStockUnitsRSU0.00.00.00.00.00.00.00.00.00.00.00.0

us-gaap:AllocatedShareBasedCompensationExpense us-gaap:IncomeStatementLocation

us-gaap:GeneralAndAdministrativeExpense


Allocated
Period End2020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-31
Value2.7942.8812.8042.2912.5172.4742.0081.8541.6622.7321.6881.6171.3121.4221.4161.4670.8930.8740.8740.9520.590.5930.520.5140.2730.2760.1640.1280.0140.020.0030.003
Percentage of AllocatedShareBasedCompensationExpense32.734.634.135.234.826.021.631.732.744.634.636.238.139.441.146.544.946.843.048.639.854.643.646.436.456.245.446.09.745.560.060.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax6.78.121.47.171.611.410.31.714.49.40.00.04.40.011.341.90.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax us-gaap:GeneralAndAdministrativeExpense0.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0

us-gaap:ResearchAndDevelopmentExpense


Allocated
Period End2020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-31
Value5.7645.4375.4274.2214.6617.047.2954.0023.4133.3883.1942.8542.1282.1832.0321.6911.0970.9921.1591.0080.8920.4930.6730.5930.4780.2150.1970.150.130.0240.0020.002
Percentage of AllocatedShareBasedCompensationExpense67.565.465.964.864.574.078.468.367.355.465.463.861.960.658.953.555.153.257.051.460.145.456.453.663.643.854.654.090.354.540.040.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax13.815.441.513.0132.632.437.43.629.511.70.00.07.10.016.348.30.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax us-gaap:ResearchAndDevelopmentExpense0.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0

Comprehensive Income Net Of Tax

us-gaap:ComprehensiveIncomeNetOfTax

us-gaap:ComprehensiveIncomeNetOfTax


Comprehensive
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-30
Value52-2.464-14.184-13.466-34.591-8.179-27.187-10.417-14.7581-16.8322.82-25.676-29.886-12.554-15.419-6.929-14.39-10.256-8.54347-5.7797.247-9.953-8.923-6.479-1.349-6.278
Percentage of ComprehensiveIncomeNetOfTax100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax77.3-7.3-33.9-38.1-264.3-25.3-773.2-47.9-75.772.7-145.69.70.00.0-41.60.0-55.4-411.10.00.00.00.00.00.00.00.00.00.0

us-gaap:ComprehensiveIncomeNetOfTax us-gaap:StatementEquityComponents

us-gaap:AccumulatedOtherComprehensiveIncome


Comprehensive
Period End2021-06-302021-03-312020-09-302020-06-302020-03-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-31
Value-0.1120.023-0.9160.427-0.105-0.1931.2841.3161.367-0.330.193-0.393-0.7110.143-0.0440.245-1.191-0.4660.1130.619-0.51
Percentage of ComprehensiveIncomeNetOfTax-0.2-0.96.8-1.21.31.9-8.71.6-8.1-11.7-0.81.35.7-0.90.6-1.711.65.50.2-10.7-7.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax-0.20.1-2.63.3-0.3-0.96.61.211.8-1.10.00.0-2.40.0-0.47.00.00.00.00.00.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax us-gaap:AccumulatedOtherComprehensiveIncome0.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0

us-gaap:RetainedEarnings


Comprehensive
Period End2021-06-302021-03-312020-09-302020-06-302020-03-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-31
Value52-2.487-12.55-35.018-8.074-10.224-16.03480-18.1993.15-25.869-29.493-11.843-15.563-6.884-14.635-9.065-8.07747-6.3987.757
Percentage of ComprehensiveIncomeNetOfTax100.2100.993.2101.298.798.1108.798.4108.1111.7100.898.794.3100.999.4101.788.494.599.8110.7107.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax77.5-7.3-35.5-267.5-24.9-47.0-82.371.5-157.410.80.00.0-39.30.0-55.1-418.10.00.00.00.00.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax us-gaap:RetainedEarnings0.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0

General And Administrative Expense

us-gaap:GeneralAndAdministrativeExpense

us-gaap:GeneralAndAdministrativeExpense


General
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-31
Value8.8638.2267.6037.6367.2317.2196.7496.2665.7585.5125.5177.4354.9584.5624.4274.1724.0914.8113.1083.0073.0433.953.4393.2332.5242.7641.9622.1821.5941.7231.3110.8420.7930.746
Percentage of GeneralAndAdministrativeExpense100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax13.124.218.221.655.222.3192.028.829.64.947.725.60.00.014.70.032.7137.50.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0

Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest

us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest

us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest


Income
Period End2020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-30
Value-13.691-12.55-35.018-8.074-27.2-10.574-15.98480-18.1993.15-25.869-29.493-12.929-15.389-6.605-14.465-9.224-8.67548-6.3987.757-10.037-8.868
Percentage of IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax-32.7-35.5-267.5-24.9-773.6-48.6-82.072.3-157.410.80.00.0-42.90.0-52.8-413.30.00.00.00.00.00.00.0

Interest Income Expense Net

us-gaap:InterestIncomeExpenseNet

us-gaap:InterestIncomeExpenseNet


Interest
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-30
Value0.1470.2150.7121.4232.093.0393.4183.6993.6152.8862.8072.6422.4831.1541.0471.045
Percentage of InterestIncomeExpenseNet100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.20.61.74.016.09.497.217.018.62.624.39.10.00.03.50.0

Interest Paid Net

us-gaap:InterestPaidNet

us-gaap:InterestPaidNet


Interest
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-31
Value5000.04000.004000.05000.06000.004000.03000.04000.07000.03000.03000.03000.05000.03000.02000.03000.0
Percentage of InterestPaidNet100.0100.00.0100.0100.0100.00.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.00.00.00.00.00.00.00.00.00.00.10.00.00.00.00.00.00.1

Net Income Loss

us-gaap:NetIncomeLoss

us-gaap:NetIncomeLoss


Net
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-31
Value52-2.487-13.691-12.55-35.018-8.074-26.912-10.224-16.03480-18.1973.15-25.869-29.493-11.843-15.562-6.885-14.635-9.065-8.07747-6.3987.757-10.037-8.868-6.444-1.349-6.278-5.044-3.751
Percentage of NetIncomeLoss100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax77.5-7.3-32.7-35.5-267.5-24.9-765.4-47.0-82.371.5-157.410.80.00.0-39.30.0-55.1-418.10.00.00.00.00.00.00.00.00.00.00.00.0

Net Income Loss Available To Common Stockholders Basic

us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic

us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic


Net
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312014-12-312014-09-302014-06-302013-12-312013-09-302013-06-30
Value52-2.487-13.691-12.55-35.018-8.074-26.912-10.224-16.03480-18.1993.15-25.869-29.493-3.072-22.652-7.725-15.475-1.349-6.278-5.044-3.703-4.18497
Percentage of NetIncomeLossAvailableToCommonStockholdersBasic100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax77.5-7.3-32.7-35.5-267.5-24.9-765.4-47.0-82.371.5-157.410.80.00.0-10.20.0-61.8-442.10.00.00.00.00.00.0

Nonoperating Income Expense

us-gaap:NonoperatingIncomeExpense

us-gaap:NonoperatingIncomeExpense


Nonoperating
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-31
Value43130.0074.1722.5820.7033.3733.7023.5882.7012.8842.4992.4211.1560.9541.1011.0651.0540.8040.580.3580.3350.3190.2750.1180.0340.0010.0090.0090.0160.0070.008-49.103-0.651
Percentage of NonoperatingIncomeExpense100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax64.038.80.011.819.72.295.917.018.42.424.98.60.00.03.20.08.530.10.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0

Operating Expenses

us-gaap:OperatingExpenses

us-gaap:OperatingExpenses


Operating
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-31
Value58495552504134363933322828302423211916171713141310.07.9697.0147.1355.8775.9515.4545.0054.9275.306
Percentage of OperatingExpenses100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax86.5146.1132.7147.3387.3127.1969.5165.6200.430.1282.397.80.00.082.30.0168.1567.40.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0

Operating Income Loss

us-gaap:OperatingIncomeLoss

us-gaap:OperatingIncomeLoss


Operating
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-31
Value9.087-15.672-13.698-16.722-37.6-8.777-30.572-14.276-19.57278-21.0820.651-28.29-30.649-13.882-16.49-7.67-15.519-10.028-9.25548-6.7337.438-10.312-8.986-6.478-1.35-6.287-5.053-3.767-3.71-1.843-1.006-3.961
Percentage of OperatingIncomeLoss100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax13.5-46.1-32.7-47.3-287.3-27.1-869.5-65.6-100.469.9-182.32.20.00.0-46.00.0-61.4-443.40.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0

Other Nonoperating Income Expense

us-gaap:OtherNonoperatingIncomeExpense

us-gaap:OtherNonoperatingIncomeExpense


Other
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302016-12-312016-09-302015-12-312015-09-302015-06-302014-12-312014-09-302014-06-302013-12-312013-09-302013-06-30
Value-0.00612-0.7052.7490.492-2.336-0.0450.003-0.027-0.1850.077-0.143-0.0620.002-0.0930.0560.030.0010.003-0.452-0.397-0.1680.0010.0090.0010.0010.0040.003
Percentage of OtherNonoperatingIncomeExpense100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax-0.038.2-1.77.83.8-7.2-1.30.0-0.1-0.20.7-0.50.00.0-0.30.00.20.00.00.00.00.00.00.00.00.00.00.0

us-gaap:OtherNonoperatingIncomeExpense us-gaap:CounterpartyName, us-gaap:TypeOfArrangement

xncr:CatabsisPharmaceuticalsInc, xncr:TechnologyLicenseAgreement


Other
Period End2021-03-31
Value12
Percentage of OtherNonoperatingIncomeExpense99.5
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax38.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax xncr:CatabsisPharmaceuticalsInc xncr:TechnologyLicenseAgreement0.0

xncr:MiragenViridian, xncr:TechnologyLicenseAgreement


Other
Period End2021-03-31
Value0.1
Percentage of OtherNonoperatingIncomeExpense0.8
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.3
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax xncr:MiragenViridian xncr:TechnologyLicenseAgreement0.0

Profit Loss

us-gaap:ProfitLoss

us-gaap:ProfitLoss


Profit
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-30
Value52-2.487-13.691-12.55-35.018-8.074-26.912-10.225-16.03380-18.1993.151-25.868-29.493-11.843-15.563-6.044-15.475-9.065-8.077
Percentage of ProfitLoss100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax77.5-7.3-32.7-35.5-267.5-24.9-765.4-47.0-82.371.5-157.410.90.00.0-39.30.0-48.4-442.10.00.0

Research And Development Expense

us-gaap:ResearchAndDevelopmentExpense

us-gaap:ResearchAndDevelopmentExpense


Research
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-31
Value4941474443332729332827202326201916151314141010107.4765.2055.0524.9534.2834.2284.1434.1634.1344.56
Percentage of ResearchAndDevelopmentExpense100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax73.4121.9114.6125.7332.0104.8777.6136.8170.925.2234.672.20.00.067.60.0135.4429.90.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0

Revenue From Contract With Customer Excluding Assessed Tax

us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax

us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax


Revenue
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302017-12-312017-09-302017-06-302017-03-31
Value6733413513323.51621191111129300.0123.5
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.00.0100.0100.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.00.0100.0100.0

us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax us-gaap:CounterpartyName

xncr:Aimmune


Revenue
Period End2020-12-312020-09-302020-06-302020-03-31
Value0.00.00.09.6
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.00.00.029.6
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.00.00.029.6
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax xncr:Aimmune0.00.00.0100.0

xncr:AlexionPharmaceuticalsInc


Revenue
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302018-12-312018-09-30
Value5.25.3144.33.83.32.55.45.1119.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax7.715.635.112.229.010.271.124.826.295.131.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax7.715.635.112.229.010.271.124.826.295.131.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax xncr:AlexionPharmaceuticalsInc100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

xncr:Astellas


Revenue
Period End2020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-30
Value2.60.00.70.30.20.013
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax6.20.05.30.95.70.070.8
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax6.20.05.30.95.70.070.8
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax xncr:Astellas100.00.0100.0100.0100.00.0100.0

xncr:Genentech


Revenue
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-31
Value2.30.21.20.90.80.70.70.70.6112
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax3.40.62.92.56.12.219.93.23.1100.1
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax3.40.62.92.56.12.219.93.23.1100.1
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax xncr:Genentech100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

xncr:Gilead


Revenue
Period End2020-12-312020-09-302020-06-302020-03-31
Value0.00.07.56.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.00.057.318.5
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.00.057.318.5
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax xncr:Gilead0.00.0100.0100.0

xncr:Janssen


Revenue
Period End2021-06-302021-03-31
Value1614
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax24.043.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax24.043.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax xncr:Janssen100.0100.0

xncr:MorphoSys


Revenue
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-31
Value1.2131.3250.012
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax1.840.93.171.30.038.6
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax1.840.93.171.30.038.6
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax xncr:MorphoSys100.0100.0100.0100.00.0100.0

xncr:Novartis


Revenue
Period End2021-06-302019-12-312019-09-302018-12-312018-09-30
Value410.010.00.020
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax60.90.046.00.068.9
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax60.90.046.00.068.9
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax xncr:Novartis100.00.0100.00.0100.0

xncr:OmerosCorporation


Revenue
Period End2020-12-312020-09-30
Value0.05.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.014.1
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.014.1
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax xncr:OmerosCorporation0.0100.0

xncr:VirBiotechnology


Revenue
Period End2021-06-302020-12-312020-09-302020-06-302019-12-312019-09-30
Value1.40.00.00.30.10.7
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax2.10.00.02.32.83.2
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax2.10.00.02.32.83.2
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax xncr:VirBiotechnology100.00.00.0100.0100.0100.0

us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax us-gaap:CounterpartyName, us-gaap:TypeOfArrangement

xncr:OmerosCorporation, xncr:TechnologyLicenseAgreement


Revenue
Period End2020-09-30
Value5.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax14.1
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax14.1
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax xncr:OmerosCorporation xncr:TechnologyLicenseAgreement100.0

us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax us-gaap:ProductOrService

us-gaap:License


Revenue
Period End2020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-31
Value225.07.5150.00.5-0.1111
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax52.814.157.348.20.02.3-0.599.8
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax52.814.157.348.20.02.3-0.599.8
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax us-gaap:License100.0100.0100.0100.00.0100.0100.0100.0

us-gaap:Royalty


Revenue
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-30
Value7.36.76.14.53.83.32.51.41.1
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax10.819.714.612.729.010.271.16.45.6
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax10.819.714.612.729.010.271.16.45.6
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax us-gaap:Royalty100.0100.0100.0100.0100.0100.0100.0100.0100.0

xncr:Collaboration


Revenue
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-30
Value58141.30.91.51.01.10.6140.30.120
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax86.943.63.12.511.53.131.32.873.90.30.968.9
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax86.943.63.12.511.53.131.32.873.90.30.968.9
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax xncr:Collaboration100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

xncr:Milestone


Revenue
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302018-12-312018-09-30
Value1.51212250.312-0.1194.0119.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax2.236.829.670.72.338.6-2.888.720.599.431.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax2.236.829.670.72.338.6-2.888.720.599.431.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax xncr:Milestone100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

Assets

us-gaap:Assets

us-gaap:Assets


Assets
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-31
Value6956927036466446666706866846975765855916123903984164184283223341932062111721786770768287
Percentage of Assets100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

Liabilities

us-gaap:Liabilities

us-gaap:Liabilities


Liabilities
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-31
Value481091307774737776768755537274108107114114114119125354458109.3378.53311101213
Percentage of Liabilities100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets7.015.818.612.011.511.111.511.111.212.59.59.112.212.227.727.027.627.426.737.237.618.121.527.56.15.212.615.714.215.115.8

Liabilities And Stockholders Equity

us-gaap:LiabilitiesAndStockholdersEquity

us-gaap:LiabilitiesAndStockholdersEquity


Liabilities
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-31
Value6956927036466446666706866846975765855916123903984164184283223341932062111721786770768287
Percentage of LiabilitiesAndStockholdersEquity100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

Stockholders Equity

us-gaap:StockholdersEquity

us-gaap:StockholdersEquity


Stockholders
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312012-12-312011-12-31
Value6465835725685705935936106086095215325195372822903013033132022081581621531621695959657073-166.268-157.703
Percentage of StockholdersEquity100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets93.084.281.488.088.588.988.588.988.887.590.590.987.887.872.373.072.472.673.362.862.481.978.572.593.994.887.484.385.884.984.20.00.0

us-gaap:StockholdersEquity us-gaap:StatementEquityComponents

us-gaap:AccumulatedOtherComprehensiveIncome


Stockholders
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-31
Value-0.0150.0970.0740.5671.4831.0561.1611.4361.6290.345-0.971-2.338-2.008-2.201-1.808-1.097-1.24-1.196-1.441-0.250.2160.103-0.516-0.006-0.09-0.035
Percentage of StockholdersEquity-0.00.00.00.10.30.20.20.20.30.1-0.2-0.4-0.4-0.4-0.6-0.4-0.4-0.4-0.5-0.10.10.1-0.3-0.0-0.1-0.0
Percentage of Assets-0.00.00.00.10.20.20.20.20.20.0-0.2-0.4-0.3-0.4-0.5-0.3-0.3-0.3-0.3-0.10.10.1-0.2-0.0-0.1-0.0
Percentage of Assets us-gaap:AccumulatedOtherComprehensiveIncome0.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0

us-gaap:AdditionalPaidInCapital


Stockholders
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312013-12-312012-12-312011-12-31
Value9629519379199088958878778658518458398288215705665625575524314284264244224214193023001.0431.014
Percentage of StockholdersEquity148.8163.0163.8161.7159.1151.1149.7143.8142.3139.8162.0157.6159.6152.8202.3195.0186.5183.5176.1213.0205.6268.4261.1275.4259.8247.7511.0409.1-0.6-0.6
Percentage of Assets138.3137.3133.3142.2140.8134.3132.5127.9126.3122.2146.6143.3140.1134.2146.3142.3135.0133.3129.0133.8128.3219.8205.0199.7244.0234.8446.7344.50.00.0
Percentage of Assets us-gaap:AdditionalPaidInCapital0.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0

us-gaap:CommonStock


Stockholders
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312013-12-312012-12-312011-12-31
Value0.5840.5830.580.5730.5720.570.5690.5670.5650.5640.5630.5620.5580.5560.470.470.4680.4670.4660.4110.4090.4070.4050.4050.4050.4040.3140.3140.0010.001
Percentage of StockholdersEquity0.10.10.10.10.10.10.10.10.10.10.10.10.10.10.20.20.20.20.10.20.20.30.20.30.20.20.50.4-0.0-0.0
Percentage of Assets0.10.10.10.10.10.10.10.10.10.10.10.10.10.10.10.10.10.10.10.10.10.20.20.20.20.20.50.40.00.0
Percentage of Assets us-gaap:CommonStock0.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0

us-gaap:RetainedEarnings


Stockholders
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312013-12-312012-12-312011-12-31
Value-315.974-368.222-365.735-352.044-339.494-304.476-296.402-269.49-259.266-243.232-323.277-305.078-308.229-282.361-287.286-275.443-259.88-252.996-237.96-228.895-220.818-267.983-261.585-269.342-259.305-250.437-243.993-227.571-167.312-158.718
Percentage of StockholdersEquity-48.8-63.1-63.9-61.9-59.5-51.3-50.0-44.2-42.6-39.9-62.0-57.3-59.4-52.5-101.9-94.8-86.2-83.3-75.8-113.1-105.9-168.7-161.0-175.7-160.0-147.9-411.5-309.5100.6100.6
Percentage of Assets-45.4-53.2-52.0-54.5-52.7-45.7-44.2-39.3-37.9-34.9-56.1-52.1-52.1-46.1-73.6-69.2-62.4-60.5-55.5-71.1-66.1-138.2-126.4-127.4-150.3-140.2-359.7-260.60.00.0
Percentage of Assets us-gaap:RetainedEarnings0.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0

Assets Current

us-gaap:AssetsCurrent

us-gaap:AssetsCurrent


Assets
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-31
Value4805916375706035885585735274883152862694702302172101661411102439497129691455761667378
Percentage of AssetsCurrent100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets69.185.390.788.393.688.283.383.677.070.154.749.045.676.959.254.750.739.733.134.472.948.947.261.440.481.285.186.287.388.789.4

Cash And Cash Equivalents At Carrying Value

us-gaap:CashAndCashEquivalentsAtCarryingValue

us-gaap:CashAndCashEquivalentsAtCarryingValue


Cash
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312011-12-31
Value1151761635810973505132212634352511613111314147.8778.1512571111954606672779.621113.4082.31214
Percentage of CashAndCashEquivalentsAtCarryingValue100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets16.725.523.39.017.011.17.57.54.83.14.66.06.041.14.23.42.73.23.44.62.44.26.127.36.566.680.686.086.787.989.30.00.00.00.00.0

us-gaap:CashAndCashEquivalentsAtCarryingValue us-gaap:CashAndCashEquivalents

us-gaap:MoneyMarketFunds


Cash
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-30
Value711651583410349323022151815312475.1759.33101112106.9696.8159.4539.904
Percentage of CashAndCashEquivalentsAtCarryingValue61.993.497.259.494.267.563.659.870.371.569.644.788.298.531.368.489.781.583.573.488.583.675.117.2
Percentage of Assets10.323.922.65.316.07.54.84.53.32.23.22.75.340.51.32.32.42.62.83.42.13.54.64.7
Percentage of Assets us-gaap:MoneyMarketFunds0.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0

us-gaap:CashAndCashEquivalentsAtCarryingValue us-gaap:CashAndCashEquivalents, us-gaap:FairValueByFairValueHierarchyLevel

us-gaap:MoneyMarketFunds, us-gaap:FairValueInputsLevel1


Cash
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-31
Value711651583410349323022151815312475.1759.33101112106.9696.8159.4539.9041.3792.04
Percentage of CashAndCashEquivalentsAtCarryingValue61.993.497.259.494.267.563.659.870.371.569.644.788.298.531.368.489.781.583.573.488.583.675.117.212.31.7
Percentage of Assets10.323.922.65.316.07.54.84.53.32.23.22.75.340.51.32.32.42.62.83.42.13.54.64.70.81.1
Percentage of Assets us-gaap:MoneyMarketFunds us-gaap:FairValueInputsLevel10.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0

us-gaap:CashAndCashEquivalentsAtCarryingValue us-gaap:FairValueByFairValueHierarchyLevel, us-gaap:FairValueByMeasurementFrequency, us-gaap:InvestmentType

us-gaap:FairValueInputsLevel1, us-gaap:FairValueMeasurementsRecurring, us-gaap:MoneyMarketFunds


Cash
Period End2020-12-312019-12-312018-12-312017-12-312016-12-312015-12-31
Value15832185.175129.453
Percentage of CashAndCashEquivalentsAtCarryingValue97.263.669.631.383.575.1
Percentage of Assets22.64.83.21.32.84.6
Percentage of Assets us-gaap:FairValueInputsLevel1 us-gaap:FairValueMeasurementsRecurring us-gaap:MoneyMarketFunds0.00.00.00.00.00.0

us-gaap:CashAndCashEquivalentsAtCarryingValue us-gaap:FairValueByMeasurementFrequency, us-gaap:InvestmentType

us-gaap:FairValueMeasurementsRecurring, us-gaap:MoneyMarketFunds


Cash
Period End2020-12-312019-12-312018-12-312017-12-312016-12-312015-12-31
Value15832185.175129.453
Percentage of CashAndCashEquivalentsAtCarryingValue97.263.669.631.383.575.1
Percentage of Assets22.64.83.21.32.84.6
Percentage of Assets us-gaap:FairValueMeasurementsRecurring us-gaap:MoneyMarketFunds0.00.00.00.00.00.0

us-gaap:CashAndCashEquivalentsAtCarryingValue us-gaap:InvestmentType

us-gaap:CashAndCashEquivalents


Cash
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-31
Value711651583410349323022151815312475.175
Percentage of CashAndCashEquivalentsAtCarryingValue61.993.497.259.494.267.563.659.870.371.569.644.788.298.531.3
Percentage of Assets10.323.922.65.316.07.54.84.53.32.23.22.75.340.51.3
Percentage of Assets us-gaap:CashAndCashEquivalents0.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0

us-gaap:MoneyMarketFunds


Cash
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-31
Value711651583410349323022151815312475.175
Percentage of CashAndCashEquivalentsAtCarryingValue61.993.497.259.494.267.563.659.870.371.569.644.788.298.531.3
Percentage of Assets10.323.922.65.316.07.54.84.53.32.23.22.75.340.51.3
Percentage of Assets us-gaap:MoneyMarketFunds0.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0

Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents

us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents

us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents


Cash
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302016-12-312015-12-31
Value1151761635810973505132212634352511613111412
Percentage of CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets16.725.523.39.017.011.17.57.54.83.14.66.06.041.14.23.42.73.46.1

Marketable Securities Current

us-gaap:MarketableSecuritiesCurrent

us-gaap:MarketableSecuritiesCurrent


Marketable
Period End2020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-31
Value48747449747949547231826823622021020719617714111589838483
Percentage of MarketableSecuritiesCurrent100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets75.573.574.671.572.269.045.746.540.437.234.453.249.342.633.827.027.824.943.440.5

Accounts Receivable Net Current

us-gaap:AccountsReceivableNetCurrent

us-gaap:AccountsReceivableNetCurrent


Accounts
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-31
Value1412119.5348.9256.825214.34910137102.4621.2831.0981.1420.831146.9388.6163.0891500.6490.0440.4080.4540.4112.9660.020.060.5110.059
Percentage of AccountsReceivableNetCurrent100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets2.11.81.61.51.41.03.20.61.519.81.80.40.20.20.30.23.61.72.01.045.00.30.00.20.30.24.40.00.10.60.1

us-gaap:AccountsReceivableNetCurrent us-gaap:CounterpartyName, us-gaap:ProductOrService, us-gaap:TypeOfArrangement

xncr:MorphoSys, us-gaap:Royalty, xncr:CollaborationAndLicenseAgreement


Accounts
Period End2021-06-302021-03-31
Value1.51.4
Percentage of AccountsReceivableNetCurrent10.111.2
Percentage of Assets0.20.2
Percentage of Assets xncr:MorphoSys us-gaap:Royalty xncr:CollaborationAndLicenseAgreement0.00.0

us-gaap:AccountsReceivableNetCurrent us-gaap:CounterpartyName, us-gaap:TypeOfArrangement

xncr:AlexionPharmaceuticalsInc, xncr:OptionAndLicenseAgreement


Accounts
Period End2021-06-302021-03-31
Value109.5
Percentage of AccountsReceivableNetCurrent68.875.8
Percentage of Assets1.51.4
Percentage of Assets xncr:AlexionPharmaceuticalsInc xncr:OptionAndLicenseAgreement0.00.0

Prepaid Expense And Other Assets Current

us-gaap:PrepaidExpenseAndOtherAssetsCurrent

us-gaap:PrepaidExpenseAndOtherAssetsCurrent


Prepaid
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-31
Value151410107.3986.4766.5477.533119.4331012126.6495.6067.0277.6174.3652.9013.4482.1921.8431.2010.8650.7110.4220.1340.1620.4020.1590.06
Percentage of PrepaidExpenseAndOtherAssetsCurrent100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets2.22.01.51.61.11.01.01.11.71.41.82.12.01.11.41.81.81.00.71.10.71.00.60.40.40.20.20.20.50.20.1

Property Plant And Equipment Gross

us-gaap:PropertyPlantAndEquipmentGross

us-gaap:PropertyPlantAndEquipmentGross


Property
Period End2020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-31
Value38282115109.1947.4536.684
Percentage of PropertyPlantAndEquipmentGross100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets5.54.23.73.92.54.411.07.7

us-gaap:PropertyPlantAndEquipmentGross us-gaap:PropertyPlantAndEquipmentByType

us-gaap:FurnitureAndFixtures


Property
Period End2020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-31
Value0.5270.4920.1730.1520.1250.1020.0970.089
Percentage of PropertyPlantAndEquipmentGross1.41.70.81.01.21.11.31.3
Percentage of Assets0.10.10.00.00.00.00.10.1
Percentage of Assets us-gaap:FurnitureAndFixtures0.00.00.00.00.00.00.00.0

us-gaap:LeaseholdsAndLeaseholdImprovements


Property
Period End2020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-31
Value6.9576.8314.7744.013.793.7543.0863.081
Percentage of PropertyPlantAndEquipmentGross18.024.022.526.735.640.841.446.1
Percentage of Assets1.01.00.81.00.91.84.63.5
Percentage of Assets us-gaap:LeaseholdsAndLeaseholdImprovements0.00.00.00.00.00.00.00.0

xncr:ComputersSoftwareAndEquipment


Property
Period End2020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-31
Value312116106.7355.3384.273.514
Percentage of PropertyPlantAndEquipmentGross80.774.276.772.363.258.157.352.6
Percentage of Assets4.43.12.82.81.62.66.34.0
Percentage of Assets xncr:ComputersSoftwareAndEquipment0.00.00.00.00.00.00.00.0

Accumulated Depreciation Depletion And Amortization Property Plant And Equipment

us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment

us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment


Accumulated
Period End2020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-31
Value17129.4267.9487.5456.8846.6966.5756.6536.5546.4896.4386.416.377
Percentage of AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets2.41.91.62.01.83.33.23.83.79.79.28.47.87.3

Property Plant And Equipment Net

us-gaap:PropertyPlantAndEquipmentNet

us-gaap:PropertyPlantAndEquipmentNet


Property
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-31
Value23222119161615131211119.6889.4018.9217.0886.0853.8613.363.1053.052.5082.512.312.2931.8041.3750.8990.7440.5710.340.307
Percentage of PropertyPlantAndEquipmentNet100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets3.33.23.13.12.52.52.42.01.81.62.01.71.61.51.81.50.90.80.70.90.81.31.11.11.00.81.31.00.70.40.4

Indefinite Lived Intangible Assets Excluding Goodwill

us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill us-gaap:IndefiniteLivedIntangibleAssetsByMajorClass

us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill

us-gaap:Trademarks


Indefinite
Period End2020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-31
Value399000.0399000.0399000.0399000.0399000.0399000.0400000.0369000.0
Percentage of IndefiniteLivedIntangibleAssetsExcludingGoodwill100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets0.10.10.10.10.10.20.60.4
Percentage of Assets us-gaap:Trademarks0.00.00.00.00.00.00.00.0

Intangible Assets Net Excluding Goodwill

us-gaap:IntangibleAssetsNetExcludingGoodwill

us-gaap:IntangibleAssetsNetExcludingGoodwill


Intangible
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-31
Value161515151514141413121111111111111010101010109.9719.6179.6919.5099.1168.9579.0588.8998.814
Percentage of IntangibleAssetsNetExcludingGoodwill100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets2.42.22.32.42.42.22.22.02.01.82.12.01.91.82.92.82.62.62.43.33.15.24.84.55.65.313.412.611.910.810.1

Finite Lived Intangible Assets Net

us-gaap:FiniteLivedIntangibleAssetsNet

us-gaap:FiniteLivedIntangibleAssetsNet


Finite
Period End2020-12-31
Value7146000.0
Percentage of FiniteLivedIntangibleAssetsNet100.0
Percentage of Assets1.0

Operating Lease Right Of Use Asset

us-gaap:OperatingLeaseRightOfUseAsset

us-gaap:OperatingLeaseRightOfUseAsset


Operating
Period End2020-12-312019-12-31
Value109.38
Percentage of OperatingLeaseRightOfUseAsset100.0100.0
Percentage of Assets1.51.4

Other Assets Noncurrent

us-gaap:OtherAssetsNoncurrent

us-gaap:OtherAssetsNoncurrent


Other
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-31
Value4.354100.2128.6088.7889.1880.3111010110.3110.3110.2650.2650.2650.2650.2140.1030.1030.06379101329.1759.0179.1168.9498.914
Percentage of OtherAssetsNoncurrent100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets0.61.50.01.31.41.40.01.51.61.60.10.10.00.00.10.10.10.00.00.037.558.618.013.512.711.910.810.2

Equity Securities Fv Ni

us-gaap:EquitySecuritiesFvNi

us-gaap:EquitySecuritiesFvNi


Equity
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-31
Value456.1365.3035.3822.6112.253
Percentage of EquitySecuritiesFvNi100.0100.0100.0100.0100.0100.0
Percentage of Assets6.50.90.80.80.40.3

us-gaap:EquitySecuritiesFvNi us-gaap:CounterpartyName, us-gaap:StatementClassOfStock

xncr:CatabasisPharmaceuticalsInc, us-gaap:CommonStock


Equity
Period End2021-06-30
Value8.102
Percentage of EquitySecuritiesFvNi17.9
Percentage of Assets1.2
Percentage of Assets xncr:CatabasisPharmaceuticalsInc us-gaap:CommonStock0.0

xncr:InmuneBioInc, us-gaap:CommonStock


Equity
Period End2021-06-30
Value31
Percentage of EquitySecuritiesFvNi69.0
Percentage of Assets4.5
Percentage of Assets xncr:InmuneBioInc us-gaap:CommonStock0.0

xncr:MiragenViridian, us-gaap:CommonStock


Equity
Period End2021-06-302020-12-31
Value5.8975.303
Percentage of EquitySecuritiesFvNi13.0100.0
Percentage of Assets0.80.8
Percentage of Assets xncr:MiragenViridian us-gaap:CommonStock0.00.0

us-gaap:EquitySecuritiesFvNi us-gaap:FairValueByFairValueHierarchyLevel

us-gaap:FairValueInputsLevel1


Equity
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-31
Value456.1365.3035.3822.6112.253
Percentage of EquitySecuritiesFvNi100.0100.0100.0100.0100.0100.0
Percentage of Assets6.50.90.80.80.40.3
Percentage of Assets us-gaap:FairValueInputsLevel10.00.00.00.00.00.0

us-gaap:EquitySecuritiesFvNi us-gaap:FairValueByFairValueHierarchyLevel, us-gaap:FairValueByMeasurementFrequency

us-gaap:FairValueInputsLevel1, us-gaap:FairValueMeasurementsRecurring


Equity
Period End2020-12-31
Value5.303
Percentage of EquitySecuritiesFvNi100.0
Percentage of Assets0.8
Percentage of Assets us-gaap:FairValueInputsLevel1 us-gaap:FairValueMeasurementsRecurring0.0

us-gaap:EquitySecuritiesFvNi us-gaap:FairValueByMeasurementFrequency

us-gaap:FairValueMeasurementsRecurring


Equity
Period End2020-12-31
Value5.303
Percentage of EquitySecuritiesFvNi100.0
Percentage of Assets0.8
Percentage of Assets us-gaap:FairValueMeasurementsRecurring0.0

us-gaap:EquitySecuritiesFvNi us-gaap:StatementClassOfStock

us-gaap:CommonStock


Equity
Period End2021-06-302020-12-31
Value455.303
Percentage of EquitySecuritiesFvNi100.0100.0
Percentage of Assets6.50.8
Percentage of Assets us-gaap:CommonStock0.00.0

Accounts Payable Current

us-gaap:AccountsPayableCurrent

us-gaap:AccountsPayableCurrent


Accounts
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-31
Value7.1127.6638.954131010108.3048.9945.4853.7975.9834.9168.5236.8696.6027.3794.2753.887.3347.6944.2916.45.1073.0772.5561.6912.0981.3742.1042.633
Percentage of AccountsPayableCurrent100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets1.01.11.32.01.61.51.51.21.30.80.71.00.81.41.81.71.81.00.92.32.32.23.12.41.81.42.53.01.82.63.0

Accrued Liabilities Current

us-gaap:AccruedLiabilitiesCurrent

us-gaap:AccruedLiabilitiesCurrent


Accrued
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-31
Value171217119.1577.2928.9957.8326.2265.7059.6625.6715.9234.6115.484.6363.9846.5026.6926.5363.2782.3913.6343.8172.5371.6862.2511.7641.3311.4651.393
Percentage of AccruedLiabilitiesCurrent100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets2.51.82.51.81.41.11.31.10.90.81.71.01.00.81.41.21.01.61.62.01.01.21.81.81.50.93.32.51.71.81.6

Contract With Customer Liability Current

us-gaap:ContractWithCustomerLiabilityCurrent

us-gaap:ContractWithCustomerLiabilityCurrent


Contract
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-31
Value197792434446454545594040606060
Percentage of ContractWithCustomerLiabilityCurrent100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets2.811.213.26.86.96.96.76.66.68.56.96.810.29.815.4

Liabilities Current

us-gaap:LiabilitiesCurrent

us-gaap:LiabilitiesCurrent


Liabilities
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-31
Value459912170666566646373535271731011001071061061101153443568.4086.8776.1969.935.9466.8277.479
Percentage of LiabilitiesCurrent100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets6.614.417.210.910.39.99.99.49.310.59.38.912.012.026.025.225.825.524.834.434.717.721.026.84.93.89.114.07.88.38.6

Operating Lease Liability Current

us-gaap:OperatingLeaseLiabilityCurrent

us-gaap:OperatingLeaseLiabilityCurrent


Operating
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-31
Value2322000.01934000.01889000.02158000.02094000.02136000.02169000.02197000.02214000.01987000.0
Percentage of OperatingLeaseLiabilityCurrent100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets0.30.30.30.30.30.30.30.30.30.3

Operating Lease Liability Noncurrent

us-gaap:OperatingLeaseLiabilityNoncurrent

us-gaap:OperatingLeaseLiabilityNoncurrent


Operating
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-31
Value2.7029.1949.7397.3787.6268.0418.5659.0829.6510
Percentage of OperatingLeaseLiabilityNoncurrent100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets0.41.31.41.11.21.21.31.31.41.5

Lessee Operating Lease Liability Payments Due Year Two

us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo

us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo


Lessee
Period End2021-06-302021-03-312020-12-312020-09-30
Value707000.01415000.02269000.02269000.0
Percentage of LesseeOperatingLeaseLiabilityPaymentsDueYearTwo100.0100.0100.0100.0
Percentage of Assets0.10.20.30.4

Lessee Operating Lease Liability Payments Due Year Three

us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree

us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree


Lessee
Period End2021-06-302021-03-312020-12-312020-09-30
Value729000.01436000.01415000.01415000.0
Percentage of LesseeOperatingLeaseLiabilityPaymentsDueYearThree100.0100.0100.0100.0
Percentage of Assets0.10.20.20.2

Lessee Operating Lease Liability Payments Due Year Four

us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour

us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour


Lessee
Period End2021-06-302021-03-312020-12-312020-09-30
Value688000.01396000.01436000.01436000.0
Percentage of LesseeOperatingLeaseLiabilityPaymentsDueYearFour100.0100.0100.0100.0
Percentage of Assets0.10.20.20.2

Lessee Operating Lease Liability Payments Due Year Five

us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive

us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive


Lessee
Period End2021-03-312020-12-312020-09-30
Value1480000.01396000.01330000.0
Percentage of LesseeOperatingLeaseLiabilityPaymentsDueYearFive100.0100.0100.0
Percentage of Assets0.20.20.2

Lessee Operating Lease Liability Payments Due After Year Five

us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive

us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive


Lessee
Period End2021-03-312020-12-312020-09-30
Value3861000.05342000.01238000.0
Percentage of LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive100.0100.0100.0
Percentage of Assets0.60.80.2

Operating Lease Liability

us-gaap:OperatingLeaseLiability

us-gaap:OperatingLeaseLiability


Operating
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-31
Value5.02411119.5369.721010111112
Percentage of OperatingLeaseLiability100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets0.71.61.71.51.51.51.61.61.71.8

Lessee Operating Lease Liability Payments Due

us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue

us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue


Lessee
Period End2021-06-302021-03-312020-12-312020-09-30
Value5.334131410
Percentage of LesseeOperatingLeaseLiabilityPaymentsDue100.0100.0100.0100.0
Percentage of Assets0.82.02.01.7

Lessee Operating Lease Liability Undiscounted Excess Amount

us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount

us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount


Lessee
Period End2021-06-302021-03-312020-12-312020-09-30
Value310000.02502000.02659000.01454000.0
Percentage of LesseeOperatingLeaseLiabilityUndiscountedExcessAmount100.0100.0100.0100.0
Percentage of Assets0.00.40.40.2

Stockholders Equity

us-gaap:StockholdersEquity

us-gaap:StockholdersEquity


Stockholders
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312012-12-312011-12-31
Value6465835725685705935936106086095215325195372822903013033132022081581621531621695959657073-166.268-157.703
Percentage of StockholdersEquity100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets93.084.281.488.088.588.988.588.988.887.590.590.987.887.872.373.072.472.673.362.862.481.978.572.593.994.887.484.385.884.984.20.00.0

us-gaap:StockholdersEquity us-gaap:StatementEquityComponents

us-gaap:AccumulatedOtherComprehensiveIncome


Stockholders
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-31
Value-0.0150.0970.0740.5671.4831.0561.1611.4361.6290.345-0.971-2.338-2.008-2.201-1.808-1.097-1.24-1.196-1.441-0.250.2160.103-0.516-0.006-0.09-0.035
Percentage of StockholdersEquity-0.00.00.00.10.30.20.20.20.30.1-0.2-0.4-0.4-0.4-0.6-0.4-0.4-0.4-0.5-0.10.10.1-0.3-0.0-0.1-0.0
Percentage of Assets-0.00.00.00.10.20.20.20.20.20.0-0.2-0.4-0.3-0.4-0.5-0.3-0.3-0.3-0.3-0.10.10.1-0.2-0.0-0.1-0.0
Percentage of Assets us-gaap:AccumulatedOtherComprehensiveIncome0.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0

us-gaap:AdditionalPaidInCapital


Stockholders
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312013-12-312012-12-312011-12-31
Value9629519379199088958878778658518458398288215705665625575524314284264244224214193023001.0431.014
Percentage of StockholdersEquity148.8163.0163.8161.7159.1151.1149.7143.8142.3139.8162.0157.6159.6152.8202.3195.0186.5183.5176.1213.0205.6268.4261.1275.4259.8247.7511.0409.1-0.6-0.6
Percentage of Assets138.3137.3133.3142.2140.8134.3132.5127.9126.3122.2146.6143.3140.1134.2146.3142.3135.0133.3129.0133.8128.3219.8205.0199.7244.0234.8446.7344.50.00.0
Percentage of Assets us-gaap:AdditionalPaidInCapital0.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0

us-gaap:CommonStock


Stockholders
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312013-12-312012-12-312011-12-31
Value0.5840.5830.580.5730.5720.570.5690.5670.5650.5640.5630.5620.5580.5560.470.470.4680.4670.4660.4110.4090.4070.4050.4050.4050.4040.3140.3140.0010.001
Percentage of StockholdersEquity0.10.10.10.10.10.10.10.10.10.10.10.10.10.10.20.20.20.20.10.20.20.30.20.30.20.20.50.4-0.0-0.0
Percentage of Assets0.10.10.10.10.10.10.10.10.10.10.10.10.10.10.10.10.10.10.10.10.10.20.20.20.20.20.50.40.00.0
Percentage of Assets us-gaap:CommonStock0.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0

us-gaap:RetainedEarnings


Stockholders
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312013-12-312012-12-312011-12-31
Value-315.974-368.222-365.735-352.044-339.494-304.476-296.402-269.49-259.266-243.232-323.277-305.078-308.229-282.361-287.286-275.443-259.88-252.996-237.96-228.895-220.818-267.983-261.585-269.342-259.305-250.437-243.993-227.571-167.312-158.718
Percentage of StockholdersEquity-48.8-63.1-63.9-61.9-59.5-51.3-50.0-44.2-42.6-39.9-62.0-57.3-59.4-52.5-101.9-94.8-86.2-83.3-75.8-113.1-105.9-168.7-161.0-175.7-160.0-147.9-411.5-309.5100.6100.6
Percentage of Assets-45.4-53.2-52.0-54.5-52.7-45.7-44.2-39.3-37.9-34.9-56.1-52.1-52.1-46.1-73.6-69.2-62.4-60.5-55.5-71.1-66.1-138.2-126.4-127.4-150.3-140.2-359.7-260.60.00.0
Percentage of Assets us-gaap:RetainedEarnings0.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0

Common Stock Value

us-gaap:CommonStockValue

us-gaap:CommonStockValue


Common
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-31
Value584000.0583000.0580000.0573000.0572000.0570000.0569000.0567000.0565000.0564000.0563000.0562000.0558000.0556000.0470000.0470000.0468000.0467000.0466000.0411000.0409000.0407000.0405000.0405000.0405000.0404000.0314000.0314000.0314000.0314000.0314000.0
Percentage of CommonStockValue100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets0.10.10.10.10.10.10.10.10.10.10.10.10.10.10.10.10.10.10.10.10.10.20.20.20.20.20.50.40.40.40.4

Additional Paid In Capital

us-gaap:AdditionalPaidInCapital

us-gaap:AdditionalPaidInCapital


Additional
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-31
Value962951937919908895887877865851845839828821570566562557552431428426424422421419302302301301300
Percentage of AdditionalPaidInCapital100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets138.3137.3133.3142.2140.8134.3132.5127.9126.3122.2146.6143.3140.1134.2146.3142.3135.0133.3129.0133.8128.3219.8205.0199.7244.0234.8446.7426.2394.9365.0344.5

Retained Earnings Accumulated Deficit

us-gaap:RetainedEarningsAccumulatedDeficit

us-gaap:RetainedEarningsAccumulatedDeficit


Retained
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-31
Value-315.974-368.222-365.735-352.044-339.494-304.476-296.402-269.49-259.266-243.232-323.277-305.078-308.229-282.361-287.286-275.443-259.88-252.996-237.96-228.895-220.818-267.983-261.585-269.342-259.305-250.437-243.993-242.644-236.366-231.322-227.571
Percentage of RetainedEarningsAccumulatedDeficit100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets-45.4-53.2-52.0-54.5-52.7-45.7-44.2-39.3-37.9-34.9-56.1-52.1-52.1-46.1-73.6-69.2-62.4-60.5-55.5-71.1-66.1-138.2-126.4-127.4-150.3-140.2-359.7-342.4-309.5-280.4-260.6

Accumulated Other Comprehensive Income Loss Net Of Tax

us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax

us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax


Accumulated
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-31
Value-15000.097000.074000.0567000.01483000.01056000.01161000.01436000.01629000.0345000.0-971000.0-2338000.0-2008000.0-2201000.0-1808000.0-1097000.0-1240000.0-1196000.0-1441000.0-250000.0216000.0103000.0-516000.0
Percentage of AccumulatedOtherComprehensiveIncomeLossNetOfTax100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets-0.00.00.00.10.20.20.20.20.20.0-0.2-0.4-0.3-0.4-0.5-0.3-0.3-0.3-0.3-0.10.10.1-0.2

Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value

us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue

us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue


Adjustments
Period End2021-06-302021-03-312020-09-302020-06-302020-03-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-31
Value9.358.2938.3188.2316.5129.5149.3035.8565.0756.124.8824.4713.443.6043.4493.1581.991.8652.0331.961.4831.0861.1931.107
Percentage of AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets0.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0

us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue us-gaap:StatementEquityComponents

us-gaap:AdditionalPaidInCapital


Adjustments
Period End2021-06-302021-03-312020-09-302020-06-302020-03-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-31
Value9.358.2938.3188.2316.5129.5149.3035.8565.0756.124.8824.4713.443.6043.4493.1581.991.8652.0331.961.4831.0861.1931.107
Percentage of AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets0.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0
Percentage of Assets us-gaap:AdditionalPaidInCapital0.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0

Net Cash Provided By Used In Operating Activities

us-gaap:NetCashProvidedByUsedInOperatingActivities

us-gaap:NetCashProvidedByUsedInOperatingActivities


Net
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-30
Value-9.654-29.96617-3.866-27.6829.46-19.577-6.477109-18.728-16.781-10.311-28.419-24.245-6.666-3.509-12.962-10.546-15.788134
Percentage of NetCashProvidedByUsedInOperatingActivities100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax-14.3-88.240.8-10.9-211.529.2-556.8-29.8560.2-16.7-145.1-35.50.00.0-22.10.0-103.7-301.30.00.0

Net Cash Provided By Used In Investing Activities

us-gaap:NetCashProvidedByUsedInInvestingActivities

us-gaap:NetCashProvidedByUsedInInvestingActivities


Net
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-30
Value-53.3093878-50.5659121522-102.43136.8665.862-190.169128.9394.9339.5258.553-104.271-127.665
Percentage of NetCashProvidedByUsedInInvestingActivities100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax-79.0112.0188.2-143.0453.938.8447.3101.4-525.712.259.420.20.00.029.60.076.2244.40.00.0

Net Cash Provided By Used In Financing Activities

us-gaap:NetCashProvidedByUsedInFinancingActivities

us-gaap:NetCashProvidedByUsedInFinancingActivities


Net
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-30
Value1.845.3399.5872.9864.01.4712.9733.0493.9730.6671.1654.1532.3082460.6210.991.0961.0261190.501
Percentage of NetCashProvidedByUsedInFinancingActivities100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax2.715.722.98.430.64.584.614.020.40.610.114.30.00.02.10.08.829.30.00.0

Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect

us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect

us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect


Cash
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-30
Value-61.12313105-51.443523-0.8771810-4.388-8.75-0.296-216.282352.8942.414
Percentage of CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax-90.639.5251.9-145.5272.972.6-24.985.654.9-3.9-75.7-1.00.00.09.60.0

Depreciation Depletion And Amortization

us-gaap:DepreciationDepletionAndAmortization

us-gaap:DepreciationDepletionAndAmortization


Depreciation
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-31
Value1753000.01638000.01532000.01446000.01443000.01373000.01225000.01070000.01007000.0996000.0883000.0816000.0822000.0730000.0610000.0556000.0454000.0410000.0467000.0371000.0346000.0282000.0345000.0274000.0254000.0240000.0261000.0135000.0166000.0320000.0278000.0134000.0160000.0139000.0
Percentage of DepreciationDepletionAndAmortization100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

Increase Decrease In Accounts Payable

us-gaap:IncreaseDecreaseInAccountsPayable

us-gaap:IncreaseDecreaseInAccountsPayable


Increase
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-31
Value-551000.0-1291000.0-4155000.02596000.0200000.0124000.01884000.0-689000.03508000.01689000.0-2186000.01067000.0-3607000.01654000.0267000.0-778000.03105000.0395000.0-3454000.0-360000.03403000.0-2109000.01293000.02030000.0688000.0699000.0-407000.0723000.0-730000.0-529000.0-727000.0585000.0-149000.01610000.0
Percentage of IncreaseDecreaseInAccountsPayable100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

Net Cash Provided By Used In Operating Activities

us-gaap:NetCashProvidedByUsedInOperatingActivities

us-gaap:NetCashProvidedByUsedInOperatingActivities


Net
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-30
Value-9.654-29.96617-3.866-27.6829.46-19.577-6.477109-18.728-16.781-10.311-28.419-24.245-6.666-3.509-12.962-10.546-15.788134
Percentage of NetCashProvidedByUsedInOperatingActivities100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax-14.3-88.240.8-10.9-211.529.2-556.8-29.8560.2-16.7-145.1-35.50.00.0-22.10.0-103.7-301.30.00.0

Net Income Loss

us-gaap:NetIncomeLoss

us-gaap:NetIncomeLoss


Net
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-31
Value52-2.487-13.691-12.55-35.018-8.074-26.912-10.224-16.03480-18.1973.15-25.869-29.493-11.843-15.562-6.885-14.635-9.065-8.07747-6.3987.757-10.037-8.868-6.444-1.349-6.278-5.044-3.751
Percentage of NetIncomeLoss100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax77.5-7.3-32.7-35.5-267.5-24.9-765.4-47.0-82.371.5-157.410.80.00.0-39.30.0-55.1-418.10.00.00.00.00.00.00.00.00.00.00.00.0

Profit Loss

us-gaap:ProfitLoss

us-gaap:ProfitLoss


Profit
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-30
Value52-2.487-13.691-12.55-35.018-8.074-26.912-10.225-16.03380-18.1993.151-25.868-29.493-11.843-15.563-6.044-15.475-9.065-8.077
Percentage of ProfitLoss100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax77.5-7.3-32.7-35.5-267.5-24.9-765.4-47.0-82.371.5-157.410.90.00.0-39.30.0-48.4-442.10.00.0

Share Based Compensation

us-gaap:ShareBasedCompensation

us-gaap:ShareBasedCompensation


Share
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-31
Value9.358.2938.5588.3188.2316.5127.1789.5149.3035.8565.0756.124.8824.4713.443.6043.4493.1581.991.8652.0331.961.4831.0861.1931.1070.7510.4710.3610.2780.1440.0440.0050.005
Percentage of ShareBasedCompensation100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:ShareBasedCompensation us-gaap:AwardType

us-gaap:EmployeeStock


Share
Period End2021-06-302021-03-312020-06-302020-03-31
Value0.2530.2480.2130.194
Percentage of ShareBasedCompensation2.73.02.63.0

us-gaap:EmployeeStockOption


Share
Period End2021-06-302021-03-312020-06-302020-03-31
Value7.3556.536.6675.882
Percentage of ShareBasedCompensation78.778.781.090.3

us-gaap:RestrictedStockUnitsRSU


Share
Period End2021-06-302021-03-312020-06-302020-03-31
Value1.7421.5151.3510.436
Percentage of ShareBasedCompensation18.618.316.46.7

us-gaap:ShareBasedCompensation us-gaap:IncomeStatementLocation

us-gaap:GeneralAndAdministrativeExpense


Share
Period End2021-06-302021-03-312020-06-302020-03-31
Value3.1932.7372.8042.291
Percentage of ShareBasedCompensation34.133.034.135.2

us-gaap:ResearchAndDevelopmentExpense


Share
Period End2021-06-302021-03-312020-06-302020-03-31
Value6.1575.5565.4274.221
Percentage of ShareBasedCompensation65.967.065.964.8

Net Cash Provided By Used In Investing Activities

us-gaap:NetCashProvidedByUsedInInvestingActivities

us-gaap:NetCashProvidedByUsedInInvestingActivities


Net
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-30
Value-53.3093878-50.5659121522-102.43136.8665.862-190.169128.9394.9339.5258.553-104.271-127.665
Percentage of NetCashProvidedByUsedInInvestingActivities100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax-79.0112.0188.2-143.0453.938.8447.3101.4-525.712.259.420.20.00.029.60.076.2244.40.00.0

Payments To Acquire Property Plant And Equipment

us-gaap:PaymentsToAcquirePropertyPlantAndEquipment

us-gaap:PaymentsToAcquirePropertyPlantAndEquipment


Payments
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-31
Value2.2831.9513.1494.6950.6222.0732.912.5761.4520.4152.7871.0091.072.3461.4772.5780.7620.4940.2740.740.1760.3170.2060.6090.540.5750.220.2240.270.0660.00.10.00.036
Percentage of PaymentsToAcquirePropertyPlantAndEquipment100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.00.0100.00.0100.0

Net Cash Provided By Used In Financing Activities

us-gaap:NetCashProvidedByUsedInFinancingActivities

us-gaap:NetCashProvidedByUsedInFinancingActivities


Net
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-30
Value1.845.3399.5872.9864.01.4712.9733.0493.9730.6671.1654.1532.3082460.6210.991.0961.0261190.501
Percentage of NetCashProvidedByUsedInFinancingActivities100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax2.715.722.98.430.64.584.614.020.40.610.114.30.00.02.10.08.829.30.00.0

Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber us-gaap:AwardType

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber

us-gaap:EmployeeStockOption


Share
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-31
Value8759400.08778200.07751800.08146900.08231000.08162200.07174300.07231100.07285000.07199000.05966900.05876700.06219200.06252000.05093400.05044200.05073000.04987300.04045800.04027900.04090100.04093700.03370900.03377900.03383700.03248200.02826800.02799500.02593500.02487700.01794200.0
Percentage of ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice us-gaap:AwardType

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice

us-gaap:EmployeeStockOption


Share
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-31
Value28.9728.8226.2325.6625.5225.1924.0323.6323.222.8119.7119.2918.3617.6915.3215.2315.0214.4311.9511.1210.39.748.58.478.417.885.125.064.614.341.66
Percentage of ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

xncr:EmployeeAndNonEmployeeStockOption


Share
Period End2020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-31
Value26.2324.0319.7115.3211.958.55.121.660.59
Percentage of ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice100.0100.0100.0100.0100.0100.0100.0100.00.0

Deferred Tax Assets Net

us-gaap:DeferredTaxAssetsNet

us-gaap:DeferredTaxAssetsNet


Deferred
Period End2020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-31
Value8955000.04318000.03298000.03051000.04044000.03892000.03587000.03454000.0
Percentage of DeferredTaxAssetsNet100.0100.0100.0100.0100.0100.0100.0100.0

Deferred Tax Assets Valuation Allowance

us-gaap:DeferredTaxAssetsValuationAllowance

us-gaap:DeferredTaxAssetsValuationAllowance


Deferred
Period End2020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-31
Value10577826769765984
Percentage of DeferredTaxAssetsValuationAllowance100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments

us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments


Accretion
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-31
Value-846000.0-865000.0-709000.0143000.0265000.0573000.0988000.01457000.01275000.0601000.0462000.0338000.074000.0-480000.0-697000.0-792000.0-697000.0-659000.0-639000.0-522000.0-450000.0-426000.0-454000.0-402000.0-177000.0-63000.0
Percentage of AccretionAmortizationOfDiscountsAndPremiumsInvestments100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:ContractWithCustomerLiabilityRevenueRecognized us-gaap:CounterpartyName, us-gaap:ProductOrService, us-gaap:TypeOfArrangement

us-gaap:ContractWithCustomerLiabilityRevenueRecognized

xncr:AlexionPharmaceuticalsInc, us-gaap:Royalty, xncr:OptionAndLicenseAgreement


Contract
Period End2021-06-302021-03-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-31
Value5.25.34.33.83.32.51.41.10.0
Percentage of ContractWithCustomerLiabilityRevenueRecognized100.0100.0100.0100.0100.0100.0100.0100.00.0

xncr:Genentech, xncr:ResearchActivity, xncr:CollaborationAndLicenseAgreement


Contract
Period End2020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-31
Value0.90.80.70.60.70.60.3
Percentage of ContractWithCustomerLiabilityRevenueRecognized20.921.121.224.050.054.50.0

xncr:Genentech, xncr:ResearchActivity, xncr:ResearchAndLicenseAgreement


Contract
Period End2020-09-30
Value0.8
Percentage of ContractWithCustomerLiabilityRevenueRecognized18.6

xncr:MorphoSys, us-gaap:Royalty, xncr:CollaborationAndLicenseAgreement


Contract
Period End2021-06-302021-03-312020-12-312020-09-30
Value1.21.41.30.2
Percentage of ContractWithCustomerLiabilityRevenueRecognized23.126.40.04.7

xncr:MorphoSys, xncr:Milestone, xncr:CollaborationAndLicenseAgreement


Contract
Period End2021-06-302021-03-312020-06-302020-02-292020-03-312017-06-30
Value0.0120.0121212
Percentage of ContractWithCustomerLiabilityRevenueRecognized0.0235.80.0378.80.00.0

xncr:Novartis, xncr:Milestone, xncr:CollaborationAndLicenseAgreement


Contract
Period End2021-06-302019-09-30
Value1.010.0
Percentage of ContractWithCustomerLiabilityRevenueRecognized19.2714.3

xncr:VirBiotechnology, us-gaap:Royalty, xncr:PatentLicenseAgreement


Contract
Period End2021-06-30
Value0.9
Percentage of ContractWithCustomerLiabilityRevenueRecognized17.3

xncr:ZenasBioPharmaLimited, us-gaap:License, xncr:LicenseAgreement


Contract
Period End2020-12-31
Value16
Percentage of ContractWithCustomerLiabilityRevenueRecognized0.0

us-gaap:ContractWithCustomerLiabilityRevenueRecognized us-gaap:CounterpartyName, us-gaap:TypeOfArrangement

xncr:Aimmune, xncr:LicenseDevelopmentAndCommercializationAgreement


Contract
Period End2020-12-312020-09-302020-06-302020-03-31
Value0.00.00.09.6
Percentage of ContractWithCustomerLiabilityRevenueRecognized0.00.00.0290.9

xncr:AlexionPharmaceuticalsInc, xncr:OptionAndLicenseAgreement


Contract
Period End2020-12-312020-09-302019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-31
Value144.32.55.44.00.0119.00.00.00.00.00.00.0
Percentage of ContractWithCustomerLiabilityRevenueRecognized0.0100.0100.0385.7363.60.00.00.00.00.00.00.00.00.0

xncr:Astellas, xncr:ResearchAndLicenseAgreement


Contract
Period End2020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-31
Value0.00.70.30.20.0130.0
Percentage of ContractWithCustomerLiabilityRevenueRecognized0.018.49.18.00.01254.50.0

xncr:Genentech, xncr:CollaborationAndLicenseAgreement


Contract
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-31
Value2.30.21.20.90.80.70.70.70.6112
Percentage of ContractWithCustomerLiabilityRevenueRecognized44.23.80.020.921.121.228.050.054.50.0

xncr:Gilead, xncr:LicenseAgreement


Contract
Period End2020-09-302020-06-302020-04-302020-03-31
Value0.07.57.56.0
Percentage of ContractWithCustomerLiabilityRevenueRecognized0.0197.40.0181.8

xncr:JanssenBiotechInc, xncr:CollaborationAndLicenseAgreement


Contract
Period End2021-06-302021-03-31
Value1614
Percentage of ContractWithCustomerLiabilityRevenueRecognized311.5275.5

xncr:MorphoSys, xncr:CollaborationAndLicenseAgreement


Contract
Period End2020-09-302020-07-312020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-31
Value25250.0120.00.00.00.00.00.00.00.0
Percentage of ContractWithCustomerLiabilityRevenueRecognized581.40.00.0378.80.00.00.00.00.00.00.00.0

xncr:VirBiotechnology, xncr:ResearchAndLicenseAgreement


Contract
Period End2020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-31
Value0.00.30.0020190.10.70.00.002019
Percentage of ContractWithCustomerLiabilityRevenueRecognized0.07.90.14.050.00.00.0

us-gaap:DebtSecuritiesAvailableForSaleUnrealizedGainLoss

us-gaap:DebtSecuritiesAvailableForSaleUnrealizedGainLoss


Debt
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-31
Value-113000.023000.0-493000.0-916000.0427000.0-105000.0-275000.0-193000.01284000.01316000.01367000.0-330000.0193000.0-393000.0-711000.0
Percentage of DebtSecuritiesAvailableForSaleUnrealizedGainLoss100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:EquitySecuritiesFvNiGainLoss

us-gaap:EquitySecuritiesFvNiGainLoss


Equity
Period End2021-06-302021-03-312020-06-302020-03-31
Value43120.358-2.336
Percentage of EquitySecuritiesFvNiGainLoss100.0100.0100.0100.0

us-gaap:EquitySecuritiesFvNiRealizedGainLoss

us-gaap:EquitySecuritiesFvNiRealizedGainLoss


Equity
Period End2021-06-302021-03-31
Value180.001
Percentage of EquitySecuritiesFvNiRealizedGainLoss100.0100.0

us-gaap:EquitySecuritiesFvNiRealizedGainLoss us-gaap:CounterpartyName, us-gaap:SubsequentEventType

xncr:Aimmune, us-gaap:SubsequentEvent


Equity
Period End2020-10-31
Value5.4
Percentage of EquitySecuritiesFvNiRealizedGainLoss0.0

us-gaap:EquitySecuritiesFvNiRealizedGainLoss us-gaap:CounterpartyName, us-gaap:TypeOfArrangement

xncr:InmuneBioInc, xncr:LicenseAgreement


Equity
Period End2021-06-30
Value18
Percentage of EquitySecuritiesFvNiRealizedGainLoss100.0

us-gaap:EquitySecuritiesFvNiUnrealizedGainLoss

us-gaap:EquitySecuritiesFvNiUnrealizedGainLoss


Equity
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-31
Value2412-1.492.80.3-2.336
Percentage of EquitySecuritiesFvNiUnrealizedGainLoss100.0100.0100.0100.0100.0100.0

us-gaap:EquitySecuritiesFvNiUnrealizedGainLoss us-gaap:CounterpartyName, us-gaap:IncomeStatementLocation, us-gaap:TypeOfArrangement

xncr:InmuneBioInc, us-gaap:OtherIncome, xncr:LicenseAgreement


Equity
Period End2021-06-30
Value27
Percentage of EquitySecuritiesFvNiUnrealizedGainLoss112.5

us-gaap:EquitySecuritiesFvNiUnrealizedGainLoss us-gaap:CounterpartyName, us-gaap:TypeOfArrangement

xncr:CatabasisPharmaceuticalsInc, xncr:TechnologyLicenseAgreement


Equity
Period End2021-06-30
Value-3.7
Percentage of EquitySecuritiesFvNiUnrealizedGainLoss-15.0

xncr:InmuneBioInc, xncr:LicenseAgreement


Equity
Period End2021-06-30
Value27
Percentage of EquitySecuritiesFvNiUnrealizedGainLoss112.9

xncr:MiragenViridian, xncr:TechnologyLicenseAgreement


Equity
Period End2021-06-30
Value0.5
Percentage of EquitySecuritiesFvNiUnrealizedGainLoss2.0

us-gaap:GainLossOnDispositionOfAssets1

us-gaap:GainLossOnDispositionOfAssets1


Gain
Period End2020-12-312020-09-302019-12-312019-09-302018-12-312017-12-312015-12-312015-09-302014-12-312014-09-302013-12-312013-09-30
Value01000.00-3000.08000.0-85000.0001000.0004000.0
Percentage of GainLossOnDispositionOfAssets10.0100.00.0100.0100.0100.00.00.0100.00.00.0100.0

us-gaap:IncomeLossFromEquityMethodInvestments

us-gaap:IncomeLossFromEquityMethodInvestments


Income
Period End2020-12-312020-09-302020-06-302020-03-31
Value220.00.04.589
Percentage of IncomeLossFromEquityMethodInvestments100.00.00.0100.0

us-gaap:IncreaseDecreaseInAccountsAndOtherReceivables

us-gaap:IncreaseDecreaseInAccountsAndOtherReceivables


Increase
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-31
Value2.31.0821.9090.6092.1-14.74917-5.781-127.6111277.7251.180.184-0.0440.311-14.0457.938-1.6785.528-147.2661490.604
Percentage of IncreaseDecreaseInAccountsAndOtherReceivables100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable

us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable


Increase
Period End2020-09-302019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-30
Value804000.0-400000.0704000.0900000.0-1000.01000.00-157000.0156000.0-455000.0280000.0110000.0-335000.0-1381000.0
Percentage of IncreaseDecreaseInAccruedIncomeTaxesPayable100.0100.0100.0100.0100.0100.00.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:IncreaseDecreaseInAccruedInvestmentIncomeReceivable

us-gaap:IncreaseDecreaseInAccruedInvestmentIncomeReceivable


Increase
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-31
Value-185000.0-311000.0-55000.0-221000.0-699000.0-215000.0384000.0-151000.0185000.0-31000.0-89000.029000.0286000.0309000.0-295000.0444000.0-335000.0479000.0-11000.0701000.0-119000.0-41000.0239000.0-11000.0524000.0146000.0
Percentage of IncreaseDecreaseInAccruedInvestmentIncomeReceivable100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:IncreaseDecreaseInAccruedLiabilities

us-gaap:IncreaseDecreaseInAccruedLiabilities


Increase
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-31
Value4815000.0-5090000.06222000.02224000.01865000.0-1703000.01163000.01606000.0521000.0-3957000.03990000.0-251000.01312000.0-869000.0844000.0652000.0-2518000.0-190000.0156000.03259000.0886000.0-1243000.0-183000.01280000.0851000.0-523000.0487000.0434000.0-134000.072000.0606000.0-28000.096000.0-565000.0
Percentage of IncreaseDecreaseInAccruedLiabilities100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:IncreaseDecreaseInContractWithCustomerAsset

us-gaap:IncreaseDecreaseInContractWithCustomerAsset


Increase
Period End2021-06-302021-03-312020-12-31
Value-12.00.06212
Percentage of IncreaseDecreaseInContractWithCustomerAsset100.0100.0100.0

us-gaap:IncreaseDecreaseInContractWithCustomerLiability

us-gaap:IncreaseDecreaseInContractWithCustomerLiability


Increase
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312017-12-31
Value-58.621-14.79448-0.845-1.491-0.955-1.061-0.586-14.362230.0-20.05
Percentage of IncreaseDecreaseInContractWithCustomerLiability100.0100.0100.0100.0100.0100.0100.0100.0100.0100.00.0100.0

us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets

us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets


Increase
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-30
Value1430000.03438000.0541000.02786000.0914000.0-71000.0-985000.0-3775000.01874000.0-942000.0-1766000.067000.05425000.01043000.0-1266000.0-756000.03262000.01465000.0-588000.01257000.0348000.0683000.0353000.0181000.0392000.0142000.011000.0-238000.0201000.099000.0-1096000.0912000.0
Percentage of IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:LeaseCost

us-gaap:LeaseCost


Lease
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-30
Value632000.0624000.0628000.0669000.0686000.0670000.0661000.0659000.0697000.0
Percentage of LeaseCost100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments

us-gaap:MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments


Marketable
Period End2020-12-312020-09-302016-12-312015-12-31
Value00-1000.01000.0
Percentage of MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments0.00.0100.0100.0

us-gaap:MarketableSecuritiesUnrealizedGainLoss

us-gaap:MarketableSecuritiesUnrealizedGainLoss


Marketable
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-31
Value-112000.023000.0-493000.0-916000.0427000.0-105000.0-275000.0-193000.01284000.01316000.01367000.0-330000.0193000.0-393000.0-711000.0143000.0-44000.0245000.0-1191000.0-466000.0113000.0619000.0-510000.084000.0-55000.0-35000.0
Percentage of MarketableSecuritiesUnrealizedGainLoss100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:NoncashProjectAbandonmentCosts

us-gaap:NoncashProjectAbandonmentCosts


Noncash
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-31
Value117000.0193000.0132000.0236000.0139000.028000.0106000.025000.032000.058000.0121000.068000.045000.05000.0123000.048000.0216000.09000.0249000.062000.036000.09000.016000.0226000.017000.037000.013000.0365000.0121000.010000.0-36000.065000.08000.0168000.0
Percentage of NoncashProjectAbandonmentCosts100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:OperatingLeaseCost

us-gaap:OperatingLeaseCost


Operating
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-31
Value614000.0614000.0607000.0599000.0648000.0700000.0648000.0648000.0650000.0700000.0
Percentage of OperatingLeaseCost100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:OperatingLeasePayments

us-gaap:OperatingLeasePayments


Operating
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-31
Value548000.0499000.0583000.0527000.0566000.0700000.0544000.0531000.0344000.0700000.0
Percentage of OperatingLeasePayments100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:PaymentsToAcquireIntangibleAssets

us-gaap:PaymentsToAcquireIntangibleAssets


Payments
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-31
Value1252000.072000.01086000.0676000.0929000.0538000.0753000.0768000.01113000.01051000.0633000.0420000.0493000.0389000.0447000.0428000.0390000.0702000.0295000.0446000.0418000.0343000.0525000.0305000.0344000.0571000.0368000.0349000.0406000.0382000.011000.0288000.0338000.0521000.0
Percentage of PaymentsToAcquireIntangibleAssets100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:PaymentsToAcquireMarketableSecurities

us-gaap:PaymentsToAcquireMarketableSecurities


Payments
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-31
Value14784166174159142144107194494645254312715266.988114195-9.21716472010047
Percentage of PaymentsToAcquireMarketableSecurities100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions

us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions


Proceeds
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-03-31
Value0.9035.3398.8852.9863.2751.4712.3143.0493.2390.6670.5494.1531.8051.110.1280.9890.6541.0260.2120.5010.2470.20.0110.1140.2490.180.0010.004
Percentage of ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities

us-gaap:ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities


Proceeds
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-31
Value971242491292201571641339464565265473823361610680.0266.35
Percentage of ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.00.0100.0100.0

us-gaap:ProceedsFromStockPlans

us-gaap:ProceedsFromStockPlans


Proceeds
Period End2020-12-312020-09-302019-12-312019-09-302018-12-312018-09-302017-12-312017-09-302016-12-312016-09-302015-12-312015-09-302014-12-31
Value702000.00659000.00616000.00493000.01000.0319000.00376000.00177000.0
Percentage of ProceedsFromStockPlans100.00.0100.00.0100.00.0100.0100.0100.00.0100.00.0100.0

us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability

us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability


Right
Period End2020-12-312020-09-302020-06-30
Value2700000.0300000.0100000.0
Percentage of RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability100.0100.0100.0

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue us-gaap:AwardType

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue

us-gaap:RestrictedStockUnitsRSU


Share
Period End2021-06-302021-03-312020-12-31
Value3.832.36-0.13
Percentage of ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue100.0100.0100.0

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue us-gaap:AwardType

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue

us-gaap:RestrictedStockUnitsRSU


Share
Period End2021-06-302021-03-312020-12-31
Value-0.2643.110.59
Percentage of ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue100.0100.0100.0

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue us-gaap:AwardType

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue

us-gaap:RestrictedStockUnitsRSU


Share
Period End2021-06-302021-03-312020-12-31
Value-0.0431.751.03
Percentage of ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue100.0100.0100.0

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate us-gaap:AwardType

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate

us-gaap:EmployeeStockOption


Share
Period End2021-06-302021-03-312020-09-302020-06-302020-03-312019-09-302019-06-302019-03-312018-09-302018-06-302018-03-312017-09-302017-06-302017-03-312016-09-302016-06-302016-03-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-30
Value55.355.656.20.5610.5390.6080.6130.6130.7280.7290.7310.9670.8890.8920.7930.7610.7580.8650.7560.76600.7740.7520.7520.2990.568
Percentage of ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.00.0100.0100.0100.0100.0100.0

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum us-gaap:AwardType

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum

us-gaap:EmployeeStock


Share
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302019-12-312019-09-302019-06-302018-12-312018-09-302018-06-302017-12-312017-09-302017-06-302016-12-312016-09-302016-06-30
Value66.466.43.7762.60.626-0.00030.7140.71400.7140.71400.7980.7980.0020.7960.796
Percentage of ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum100.0100.0100.0100.0100.0100.0100.0100.00.0100.0100.00.0100.0100.0100.0100.0100.0

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum us-gaap:AwardType

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum

us-gaap:EmployeeStock


Share
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302019-12-312019-09-302019-06-302018-12-312018-09-302018-06-302017-12-312017-09-302017-06-302016-12-312016-09-302016-06-30
Value46.150.8-0.0350.80.508-0.04230.550.55-0.0420.6120.61200.6780.67800.6780.678
Percentage of ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.00.0100.0100.00.0100.0100.0

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate us-gaap:AwardType

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate

us-gaap:EmployeeStockOption


Share
Period End2021-06-302021-03-312020-09-302020-06-302020-03-312019-09-302019-06-302019-03-312018-09-302018-06-302018-03-312017-09-302017-06-302017-03-312016-09-302016-06-302016-03-312015-09-302015-06-302015-03-312014-09-302014-06-302014-03-312013-09-302013-03-31
Value1.031.020.350.00410.01710.01520.02070.02530.02870.02770.0250.01950.01910.02070.01230.01360.01560.01950.0160.01610.02020.01930.02010.01960.0219
Percentage of ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum us-gaap:AwardType

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum

us-gaap:EmployeeStock


Share
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-31
Value1.651.6501.650.01650.016500.0270.0270.0270.00290.02410.02410.0180.00710.01090.01090.009300.00930.00930.0093
Percentage of ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum100.0100.00.0100.0100.0100.00.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.00.0100.0100.0100.0

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum us-gaap:AwardType

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum

us-gaap:EmployeeStock


Share
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-31
Value0.040.09-0.090.180.00180.015600.01470.01470.014700.01470.01470.014700.00470.00470.005500.00470.00470.0055
Percentage of ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum100.0100.0100.0100.0100.0100.00.0100.0100.0100.00.0100.0100.0100.00.0100.0100.0100.00.0100.0100.0100.0

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod us-gaap:AwardType

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod

us-gaap:EmployeeStockOption


Share
Period End2021-06-302021-03-31
Value132620.064824.0
Percentage of ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod100.0100.0

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross us-gaap:AwardType

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross

us-gaap:EmployeeStockOption


Share
Period End2021-06-302021-03-312020-09-302020-06-302020-03-312019-09-302019-06-302019-03-312018-09-302018-06-302018-03-312017-09-302017-06-302017-03-312016-09-302016-06-302016-03-312015-09-302015-06-302015-03-312014-09-302014-06-302014-03-312013-09-302013-06-302013-03-31
Value166660.01321900.0129080.0296280.01137400.0219790.0356140.01342400.0126000.0159750.01393600.082000.0220500.01135600.0137000.0181000.0957000.020500.0189500.0720250.01019000.0110000.0700500.0000
Percentage of ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.00.00.00.0

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue us-gaap:AwardType

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue

us-gaap:EmployeeStockOption


Share
Period End2021-06-302021-03-312020-09-302020-06-302020-03-312019-09-302019-06-302019-03-312018-09-302018-06-302018-03-312017-09-302017-06-302017-03-312016-09-302016-06-302016-03-312015-09-302015-06-302015-03-312014-09-302014-06-302014-03-31
Value-0.2922.830.16-0.216.64-0.03-0.4621.20.710.7416.12-0.0416.9516.950.818.458.30.150.0410.54-0.24-0.097.44
Percentage of ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice us-gaap:AwardType

us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice

us-gaap:EmployeeStockOption


Share
Period End2021-06-302021-03-31
Value-1.1223.14
Percentage of ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice100.0100.0

us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice us-gaap:AwardType

us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice

us-gaap:EmployeeStockOption


Share
Period End2021-06-302021-03-31
Value2.3433.0
Percentage of ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice100.0100.0

us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice us-gaap:AwardType

us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice

us-gaap:EmployeeStockOption


Share
Period End2021-06-302021-03-31
Value-0.5143.24
Percentage of ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice100.0100.0

us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised us-gaap:AwardType

us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised

us-gaap:EmployeeStockOption


Stock
Period End2021-06-302021-03-31
Value52790.0230700.0
Percentage of StockIssuedDuringPeriodSharesStockOptionsExercised100.0100.0

us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan

us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan


Stock
Period End2021-06-302020-06-302019-06-302018-12-312018-09-302018-06-302017-12-312017-09-302016-12-312016-09-302015-12-31
Value937000.0725000.0734000.0616000.00504000.0493000.01000.0319000.00376000.0
Percentage of StockIssuedDuringPeriodValueEmployeeStockPurchasePlan100.0100.0100.0100.00.0100.0100.0100.0100.00.0100.0

us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan us-gaap:StatementEquityComponents

us-gaap:AdditionalPaidInCapital


Stock
Period End2021-06-302020-06-302019-06-302018-12-312018-09-302018-06-302017-12-312017-09-302016-12-312016-09-302015-12-31
Value937000.0725000.0734000.0615000.00504000.0493000.01000.0318000.00376000.0
Percentage of StockIssuedDuringPeriodValueEmployeeStockPurchasePlan100.0100.0100.099.80.0100.0100.0100.099.70.0100.0

us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures us-gaap:StatementEquityComponents

us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures

us-gaap:AdditionalPaidInCapital


Stock
Period End2021-03-31
Value-1000.0
Percentage of StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures100.0

us-gaap:CommonStock


Stock
Period End2021-03-31
Value1000.0
Percentage of StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures-100.0

us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation

us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation


Stock
Period End2021-06-302021-03-312020-09-302020-06-302020-03-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-31
Value0.9035.3392.9863.2751.4713.0493.2390.6670.5494.1541.8051.110.1280.9890.6541.0260.2120.5010.2470.20.0110.1140.2490.18
Percentage of StockIssuedDuringPeriodValueShareBasedCompensation100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation us-gaap:StatementEquityComponents

us-gaap:AdditionalPaidInCapital


Stock
Period End2021-06-302021-03-312020-09-302020-06-302020-03-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-31
Value0.9025.3372.9853.2731.473.0473.2380.6660.5494.151.8031.1080.1280.9870.6531.0250.2110.4990.2450.1980.0110.1140.2490.176
Percentage of StockIssuedDuringPeriodValueShareBasedCompensation99.9100.0100.099.999.999.9100.099.9100.099.999.999.8100.099.899.899.999.599.699.299.0100.0100.0100.097.8

us-gaap:CommonStock


Stock
Period End2021-06-302021-03-312020-09-302020-06-302020-03-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-31
Value0.0010.0020.0010.0020.0010.0020.0010.0010.00.0040.0020.0020.00.0020.0010.0010.0010.0020.0020.0020.00.00.00.004
Percentage of StockIssuedDuringPeriodValueShareBasedCompensation0.10.00.00.10.10.10.00.10.00.10.10.20.00.20.20.10.50.40.81.00.00.00.02.2

us-gaap:VariableLeaseCost

us-gaap:VariableLeaseCost


Variable
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-30
Value18000.010000.021000.070000.038000.022000.013000.011000.047000.0
Percentage of VariableLeaseCost100.0100.0100.0100.0100.0100.0100.0100.0100.0

xncr:CashConsiderationOnSaleOfOption us-gaap:CounterpartyName, us-gaap:TypeOfArrangement

xncr:CashConsiderationOnSaleOfOption

xncr:InmuneBioInc, xncr:LicenseAgreement


Cash
Period End2021-06-30
Value15
Percentage of CashConsiderationOnSaleOfOption100.0

xncr:CollaborativeArrangementNonrefundableUpfrontFees us-gaap:CounterpartyName, us-gaap:TypeOfArrangement

xncr:CollaborativeArrangementNonrefundableUpfrontFees

xncr:JanssenBiotechInc, xncr:CollaborationAndLicenseAgreement


Collaborative
Period End2020-11-30
Value50
Percentage of CollaborativeArrangementNonrefundableUpfrontFees100.0

xncr:OmerosCorporation, xncr:TechnologyLicenseAgreement


Collaborative
Period End2020-08-31
Value5.0
Percentage of CollaborativeArrangementNonrefundableUpfrontFees0.0

xncr:CollaborativeArrangementPercentageEquityPrivateCompany us-gaap:CounterpartyName, us-gaap:TypeOfArrangement

xncr:CollaborativeArrangementPercentageEquityPrivateCompany

xncr:PrivateBiotechCompany, xncr:LicenseAgreement


Collaborative
Period End2020-11-30
Value15.0
Percentage of CollaborativeArrangementPercentageEquityPrivateCompany100.0

xncr:ZenasBioPharmaLimited, xncr:LicenseAgreement


Collaborative
Period End2020-11-30
Value15.0
Percentage of CollaborativeArrangementPercentageEquityPrivateCompany100.0

xncr:ConsiderationOnSaleOfOption us-gaap:CounterpartyName, us-gaap:TypeOfArrangement

xncr:ConsiderationOnSaleOfOption

xncr:InmuneBioInc, xncr:LicenseAgreement


Consideration
Period End2021-06-30
Value18
Percentage of ConsiderationOnSaleOfOption100.0

xncr:ConsiderationOnSaleOfOptionEquityIssuedValue us-gaap:CounterpartyName, us-gaap:TypeOfArrangement

xncr:ConsiderationOnSaleOfOptionEquityIssuedValue

xncr:InmuneBioInc, xncr:LicenseAgreement


Consideration
Period End2021-06-30
Value3300000.0
Percentage of ConsiderationOnSaleOfOptionEquityIssuedValue100.0

xncr:IncreaseDecreaseInLeaseLiabilitiesAndRightOfUseAssets

xncr:IncreaseDecreaseInLeaseLiabilitiesAndRightOfUseAssets


Increase
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-31
Value-41000.0-42000.0-157000.0-58000.0-56000.0-54000.01464000.0-45000.0194000.0-259000.0
Percentage of IncreaseDecreaseInLeaseLiabilitiesAndRightOfUseAssets100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

xncr:NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationShareValue us-gaap:CounterpartyName, us-gaap:TypeOfArrangement

xncr:NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationShareValue

xncr:MiragenViridian, xncr:TechnologyLicenseAgreement


Noncash
Period End2020-12-31
Value6.0
Percentage of NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationShareValue100.0

xncr:PrivateBiotechCompany, xncr:LicenseAgreement


Noncash
Period End2020-11-30
Value16
Percentage of NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationShareValue0.0

xncr:ZenasBioPharmaLimited, xncr:LicenseAgreement


Noncash
Period End2020-11-30
Value16
Percentage of NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationShareValue0.0

xncr:RentExpensePerSquareFoot us-gaap:StatementScenario, us-gaap:PropertyPlantAndEquipmentByType

xncr:RentExpensePerSquareFoot

srt:ScenarioForecast, xncr:PasadenaCaOfficeAndLaboratorySpace


Rent
Period End2022-07-01
Value4.65
Percentage of RentExpensePerSquareFoot100.0

xncr:ShareBasedCompensationArrangementByShareBasedPaymentAwardAnnualPercentageIncreaseInSharesAuthorized us-gaap:PlanName

xncr:ShareBasedCompensationArrangementByShareBasedPaymentAwardAnnualPercentageIncreaseInSharesAuthorized

xncr:EquityIncentivePlan2013


Share
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302014-01-02
Value04.003.9600.040000.040000.040000.040000.04000.04
Percentage of ShareBasedCompensationArrangementByShareBasedPaymentAwardAnnualPercentageIncreaseInSharesAuthorized0.0100.00.0100.00.0100.00.00.00.0100.00.00.00.0100.00.00.00.0100.00.00.00.0100.00.00.0100.0

xncr:ShareBasedCompensationArrangementByShareBasedPaymentAwardAnnualPercentageIncreaseInSharesAuthorized us-gaap:Range, us-gaap:AwardType

srt:Maximum, us-gaap:EmployeeStock


Share
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-31
Value01.000.9900.010000.010
Percentage of ShareBasedCompensationArrangementByShareBasedPaymentAwardAnnualPercentageIncreaseInSharesAuthorized0.025.00.025.00.025.00.00.00.025.00.0

xncr:TaxRefundReceived us-gaap:IncomeTaxAuthority

xncr:TaxRefundReceived

us-gaap:DomesticCountry


Tax
Period End2020-09-30
Value800000.0
Percentage of TaxRefundReceived100.0

us-gaap:AssetsFairValueDisclosure

us-gaap:AssetsFairValueDisclosure


Assets
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-30
Value576593615559581588583599616506522528551578351368377390401297167177190149
Percentage of AssetsFairValueDisclosure100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:AssetsFairValueDisclosure us-gaap:FairValueByFairValueHierarchyLevel

us-gaap:FairValueInputsLevel1


Assets
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-31
Value1161711643910552323022151815312475.1759.33101112106.9696.8159.4539.9041.3792.04
Percentage of AssetsFairValueDisclosure20.328.926.77.118.28.95.55.13.73.13.53.05.642.81.52.52.72.83.03.64.23.85.06.60.00.0

us-gaap:FairValueInputsLevel2


Assets
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-31
Value44239343551947553655056959349050451252033034635936737938828716017018013914747
Percentage of AssetsFairValueDisclosure76.766.470.792.981.891.194.594.996.396.996.597.094.457.298.597.597.397.297.096.495.896.295.093.40.00.0

us-gaap:FairValueInputsLevel3


Assets
Period End2021-06-302021-03-312020-12-31
Value172816
Percentage of AssetsFairValueDisclosure3.04.82.6

us-gaap:AssetsFairValueDisclosure us-gaap:FairValueByFairValueHierarchyLevel, us-gaap:FairValueByMeasurementFrequency

us-gaap:FairValueInputsLevel1, us-gaap:FairValueMeasurementsRecurring


Assets
Period End2020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-31
Value16432185.175129.45354
Percentage of AssetsFairValueDisclosure26.75.53.51.53.05.00.0

us-gaap:FairValueInputsLevel2, us-gaap:FairValueMeasurementsRecurring


Assets
Period End2020-12-312019-12-312018-12-312017-12-312016-12-312015-12-31
Value435550504346388180
Percentage of AssetsFairValueDisclosure70.794.596.598.597.095.0

us-gaap:FairValueInputsLevel3, us-gaap:FairValueMeasurementsRecurring


Assets
Period End2020-12-31
Value16
Percentage of AssetsFairValueDisclosure2.6

us-gaap:AssetsFairValueDisclosure us-gaap:FairValueByMeasurementFrequency

us-gaap:FairValueMeasurementsRecurring


Assets
Period End2020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-31
Value61558352235140119054
Percentage of AssetsFairValueDisclosure100.0100.0100.0100.0100.0100.00.0

us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax

us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax


Available
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-30
Value49000.0119000.094000.0581000.01496000.01656000.01201000.01455000.01686000.0659000.0188000.01000.021000.0
Percentage of AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax us-gaap:InvestmentType

us-gaap:CorporateDebtSecurities


Available
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-30
Value13000.012000.057000.0377000.0786000.022000.0195000.0228000.0219000.069000.01000.01000.0
Percentage of AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax26.510.160.664.952.51.316.215.713.010.50.5100.0

us-gaap:USTreasuryAndGovernment


Available
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-06-30
Value36000.0107000.037000.0204000.0710000.01634000.01006000.01227000.01467000.0590000.0187000.021000.0
Percentage of AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax73.589.939.435.147.598.783.884.387.089.599.5100.0

us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax

us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax


Available
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-31
Value54000.012000.09000.04000.03000.0590000.030000.010000.047000.0305000.01149000.02330000.02019000.02191000.01799000.0
Percentage of AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax us-gaap:InvestmentType

us-gaap:CorporateDebtSecurities


Available
Period End2021-06-302021-03-312020-12-312020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-31
Value31000.05000.06000.0590000.030000.010000.02000.071000.0345000.0471000.0654000.0830000.0590000.0
Percentage of AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax57.441.766.7100.0100.0100.04.323.330.020.232.437.932.8

us-gaap:USTreasuryAndGovernment


Available
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-31
Value23000.07000.03000.04000.03000.045000.0234000.0804000.01859000.01365000.01361000.01209000.0
Percentage of AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax42.658.333.3100.0100.095.776.770.079.867.662.167.2

us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis

us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis


Available
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-31
Value442393435518473535549567591490505515522333360368380390287160170181
Percentage of AvailableForSaleDebtSecuritiesAmortizedCostBasis100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis us-gaap:InvestmentType

us-gaap:CorporateDebtSecurities


Available
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-31
Value104731192312663332812171981051059896113123
Percentage of AvailableForSaleDebtSecuritiesAmortizedCostBasis23.718.827.544.656.362.351.238.333.521.520.819.118.534.10.0

us-gaap:USTreasuryAndGovernment


Available
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-31
Value337319315287207201268350393384399416425219224
Percentage of AvailableForSaleDebtSecuritiesAmortizedCostBasis76.381.272.555.443.737.748.861.766.578.579.280.981.565.90.0

us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost

us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost


Available
Period End2021-06-302021-03-312020-12-312020-09-302017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-31
Value153251.0331163191238274197778697
Percentage of AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue

us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue


Available
Period End2021-06-302021-03-312020-12-312020-09-302017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-31
Value153251.0331163190237273197778696
Percentage of AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost

us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost


Available
Period End2021-06-302021-03-312020-12-312020-09-302017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-31
Value28836843448719617714111589838483
Percentage of AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue

us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue


Available
Period End2021-06-302021-03-312020-12-312020-09-302017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-31
Value28836843448719617714111589838483
Percentage of AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:AvailableForSaleSecuritiesDebtSecurities

us-gaap:AvailableForSaleSecuritiesDebtSecurities


Available
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-31
Value442393435519475536550569593490504512520330359367379388287160170180
Percentage of AvailableForSaleSecuritiesDebtSecurities100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:AvailableForSaleSecuritiesDebtSecurities us-gaap:BalanceSheetLocation

xncr:MarketableSecurities


Available
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-31
Value442393435519475536550569593490504512520330346
Percentage of AvailableForSaleSecuritiesDebtSecurities100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.00.0

us-gaap:AvailableForSaleSecuritiesDebtSecurities us-gaap:FairValueByFairValueHierarchyLevel, us-gaap:FairValueByMeasurementFrequency, us-gaap:InvestmentType

us-gaap:FairValueInputsLevel2, us-gaap:FairValueMeasurementsRecurring, us-gaap:CorporateDebtSecurities


Available
Period End2020-12-312019-12-312018-12-312017-12-31
Value119281104123
Percentage of AvailableForSaleSecuritiesDebtSecurities27.551.120.80.0

us-gaap:FairValueInputsLevel2, us-gaap:FairValueMeasurementsRecurring, us-gaap:USTreasuryAndGovernment


Available
Period End2020-12-312019-12-312018-12-312017-12-31
Value315269399223
Percentage of AvailableForSaleSecuritiesDebtSecurities72.548.979.20.0

us-gaap:AvailableForSaleSecuritiesDebtSecurities us-gaap:FairValueByFairValueHierarchyLevel, us-gaap:InvestmentType

us-gaap:FairValueInputsLevel2, us-gaap:CorporateDebtSecurities


Available
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302017-12-31
Value1047311923126733228121719810510498123
Percentage of AvailableForSaleSecuritiesDebtSecurities23.718.827.544.656.362.151.138.233.421.520.819.10.0

us-gaap:FairValueInputsLevel2, us-gaap:USTreasuryAndGovernment


Available
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302017-12-31
Value337320315287207203269351395385399414223
Percentage of AvailableForSaleSecuritiesDebtSecurities76.381.272.555.443.737.948.961.866.678.579.280.90.0

us-gaap:AvailableForSaleSecuritiesDebtSecurities us-gaap:FairValueByMeasurementFrequency, us-gaap:InvestmentType

us-gaap:FairValueMeasurementsRecurring, us-gaap:CorporateDebtSecurities


Available
Period End2020-12-312019-12-312018-12-312017-12-31
Value119281104123
Percentage of AvailableForSaleSecuritiesDebtSecurities27.551.120.80.0

us-gaap:FairValueMeasurementsRecurring, us-gaap:USTreasuryAndGovernment


Available
Period End2020-12-312019-12-312018-12-312017-12-31
Value315269399223
Percentage of AvailableForSaleSecuritiesDebtSecurities72.548.979.20.0

us-gaap:AvailableForSaleSecuritiesDebtSecurities us-gaap:InvestmentType

us-gaap:CorporateDebtSecurities


Available
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-31
Value104731192312673322812171981051049896112123
Percentage of AvailableForSaleSecuritiesDebtSecurities23.718.827.544.656.362.151.138.233.421.520.819.118.534.00.0

us-gaap:USTreasuryAndGovernment


Available
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-31
Value337320315287207203269351395385399414423218223
Percentage of AvailableForSaleSecuritiesDebtSecurities76.381.272.555.443.737.948.961.866.678.579.280.981.566.00.0

us-gaap:CashUninsuredAmount

us-gaap:CashUninsuredAmount


Cash
Period End2020-12-312019-12-312018-12-312017-12-31
Value163502616
Percentage of CashUninsuredAmount100.0100.0100.0100.0

us-gaap:ContractWithCustomerAssetNet us-gaap:CounterpartyName, us-gaap:ProductOrService, us-gaap:TypeOfArrangement

us-gaap:ContractWithCustomerAssetNet

xncr:AlexionPharmaceuticalsInc, xncr:Milestone, xncr:OptionAndLicenseAgreement


Contract
Period End2020-12-31
Value10.0
Percentage of ContractWithCustomerAssetNet100.0

xncr:Astellas, xncr:Milestone, xncr:ResearchAndLicenseAgreement


Contract
Period End2020-12-31
Value2.5
Percentage of ContractWithCustomerAssetNet25.0

xncr:MorphoSys, us-gaap:Royalty, xncr:CollaborationAndLicenseAgreement


Contract
Period End2020-12-31
Value1.2
Percentage of ContractWithCustomerAssetNet12.0

us-gaap:ContractWithCustomerAssetNet us-gaap:CounterpartyName, us-gaap:TypeOfArrangement

xncr:AlexionPharmaceuticalsInc, xncr:OptionAndLicenseAgreement


Contract
Period End2020-12-312019-12-31
Value8.84.1
Percentage of ContractWithCustomerAssetNet88.00.0

xncr:MorphoSys, xncr:CollaborationAndLicenseAgreement


Contract
Period End2021-03-31
Value12
Percentage of ContractWithCustomerAssetNet0.0

xncr:Novartis, xncr:CollaborationAndLicenseAgreement


Contract
Period End2020-12-312019-12-312019-06-302019-03-31
Value0.9123.02.0
Percentage of ContractWithCustomerAssetNet9.00.00.00.0

xncr:VirBiotechnology, xncr:PatentLicenseAgreement


Contract
Period End2021-06-30
Value0.5
Percentage of ContractWithCustomerAssetNet0.0

us-gaap:ContractWithCustomerAssetNet us-gaap:CounterpartyName, us-gaap:TypeOfArrangement, xncr:PotentialMilestonesType

xncr:MorphoSys, xncr:CollaborationAndLicenseAgreement, xncr:DevelopmentBasedMilestones


Contract
Period End2021-03-31
Value12
Percentage of ContractWithCustomerAssetNet0.0

us-gaap:ContractWithCustomerAssetNetCurrent

us-gaap:ContractWithCustomerAssetNetCurrent


Contract
Period End2021-06-302021-03-312020-12-31
Value0.51212
Percentage of ContractWithCustomerAssetNetCurrent100.0100.0100.0

us-gaap:ContractWithCustomerLiability

us-gaap:ContractWithCustomerLiability


Contract
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-31
Value1977924344464748486340406040
Percentage of ContractWithCustomerLiability100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:ContractWithCustomerLiability us-gaap:CounterpartyName, us-gaap:ProductOrService, us-gaap:TypeOfArrangement

xncr:Genentech, xncr:ResearchActivity, xncr:CollaborationAndLicenseAgreement


Contract
Period End2021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-31
Value2.32.53.74.65.46.16.87.58.0
Percentage of ContractWithCustomerLiability3.02.78.410.311.713.014.115.412.7

us-gaap:ContractWithCustomerLiability us-gaap:CounterpartyName, us-gaap:TypeOfArrangement

xncr:JanssenBiotechInc, xncr:CollaborationAndLicenseAgreement


Contract
Period End2021-06-302021-03-312020-12-31
Value193550
Percentage of ContractWithCustomerLiability100.045.554.0

xncr:Novartis, xncr:CollaborationAndLicenseAgreement


Contract
Period End2021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-31
Value4040404040404040404040606060
Percentage of ContractWithCustomerLiability51.543.391.689.786.885.183.282.263.5100.0100.0100.0149.90.0

us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger

us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger


Debt
Period End2021-06-302021-03-312019-12-312019-09-302019-03-312018-12-312018-09-302017-12-31
Value109181321172236276139
Percentage of DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger us-gaap:InvestmentType

us-gaap:CorporateDebtSecurities


Debt
Period End2021-06-302021-03-312020-03-312019-12-312019-09-302019-03-312018-12-312018-09-302017-12-31
Value243.06638132112202843
Percentage of DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger22.717.00.0100.0100.07.38.610.331.6

us-gaap:USTreasuryAndGovernment


Debt
Period End2021-06-302021-03-312020-09-302019-03-312018-12-312018-09-302017-12-31
Value84143115921524795
Percentage of DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger77.383.00.092.791.489.768.4

us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss

us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss


Debt
Period End2021-06-302021-03-312019-09-302018-12-312018-09-302017-12-31
Value50000.010000.09000.034000.01199000.01201000.0
Percentage of DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss100.0100.0100.0100.0100.0100.0

us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss us-gaap:InvestmentType

us-gaap:CorporateDebtSecurities


Debt
Period End2021-06-302021-03-312020-03-312019-12-312019-09-302018-12-312018-09-302017-12-31
Value27000.03000.0189000.06000.09000.034000.060000.0453000.0
Percentage of DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss54.030.00.00.0100.0100.05.037.7

us-gaap:USTreasuryAndGovernment


Debt
Period End2021-06-302021-03-312020-09-302018-12-312018-09-302017-12-31
Value23000.07000.03000.0132000.01139000.0748000.0
Percentage of DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss46.070.00.0388.295.062.3

us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months

us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months


Debt
Period End2021-06-302021-03-312020-12-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302017-12-31
Value114.10256461852318268236207
Percentage of DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months us-gaap:InvestmentType

us-gaap:CorporateDebtSecurities


Debt
Period End2021-06-302021-03-312020-12-312020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302017-12-31
Value114.10215141463.0379.82893846979
Percentage of DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months100.0100.028.00.0100.016.318.829.231.629.438.2

us-gaap:USTreasuryAndGovernment


Debt
Period End2020-12-312020-09-302020-06-302019-09-302019-06-302019-03-312018-12-312018-09-302017-12-31
Value4025491542225183167128
Percentage of DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months72.00.00.083.781.270.868.470.661.8

us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss

us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss


Debt
Period End2021-06-302021-03-312020-12-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302017-12-31
Value4000.02000.09000.024000.02000.047000.0186000.0977000.01131000.0598000.0
Percentage of DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss us-gaap:InvestmentType

us-gaap:CorporateDebtSecurities


Debt
Period End2021-06-302021-03-312020-12-312020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302017-12-31
Value4000.02000.06000.0401000.024000.01000.02000.054000.0310000.0411000.0137000.0
Percentage of DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss100.0100.066.70.0100.050.04.329.031.736.322.9

us-gaap:USTreasuryAndGovernment


Debt
Period End2020-12-312020-09-302020-06-302019-09-302019-06-302019-03-312018-12-312018-09-302017-12-31
Value3000.01000.03000.01000.045000.0132000.0667000.0720000.0461000.0
Percentage of DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss33.30.00.050.095.771.068.363.777.1

us-gaap:DebtSecuritiesCurrent

us-gaap:DebtSecuritiesCurrent


Debt
Period End2021-06-302021-03-312020-12-312019-12-31
Value288368434479
Percentage of DebtSecuritiesCurrent100.0100.0100.0100.0

us-gaap:DebtSecuritiesNoncurrent

us-gaap:DebtSecuritiesNoncurrent


Debt
Period End2021-06-302021-03-312020-12-312019-12-31
Value153251.0371
Percentage of DebtSecuritiesNoncurrent100.0100.0100.0100.0

us-gaap:DeferredIncomeTaxLiabilities

us-gaap:DeferredIncomeTaxLiabilities


Deferred
Period End2020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-31
Value8955000.04318000.03298000.03051000.04044000.03892000.03587000.03454000.0
Percentage of DeferredIncomeTaxLiabilities100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:DeferredTaxAssetsDeferredIncome

us-gaap:DeferredTaxAssetsDeferredIncome


Deferred
Period End2020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-31
Value111111265.2361.0321.8363.899
Percentage of DeferredTaxAssetsDeferredIncome100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:DeferredTaxAssetsGross

us-gaap:DeferredTaxAssetsGross


Deferred
Period End2020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-31
Value11481857073796387
Percentage of DeferredTaxAssetsGross100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:DeferredTaxAssetsOperatingLossCarryforwards

us-gaap:DeferredTaxAssetsOperatingLossCarryforwards


Deferred
Period End2020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-31
Value5636492554694758
Percentage of DeferredTaxAssetsOperatingLossCarryforwards100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:DeferredTaxAssetsPropertyPlantAndEquipment

us-gaap:DeferredTaxAssetsPropertyPlantAndEquipment


Deferred
Period End2020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-31
Value137000.0334000.0207000.0437000.0668000.0735000.0790000.0849000.0
Percentage of DeferredTaxAssetsPropertyPlantAndEquipment100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch

us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch


Deferred
Period End2020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-31
Value38282316118.0961224
Percentage of DeferredTaxAssetsTaxCreditCarryforwardsResearch100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation

us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation


Deferred
Period End2020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-31
Value8464000.04788000.01097000.0748000.0719000.0511000.0373000.0137000.0
Percentage of DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:DeferredTaxAssetsUnrealizedLossesOnAvailableforSaleSecuritiesGross

us-gaap:DeferredTaxAssetsUnrealizedLossesOnAvailableforSaleSecuritiesGross


Deferred
Period End2020-12-312018-12-312017-12-312016-12-31
Value195000.0269000.0504000.0573000.0
Percentage of DeferredTaxAssetsUnrealizedLossesOnAvailableforSaleSecuritiesGross100.0100.0100.0100.0

us-gaap:DeferredTaxLiabilitiesDeferredExpenseCapitalizedPatentCosts

us-gaap:DeferredTaxLiabilitiesDeferredExpenseCapitalizedPatentCosts


Deferred
Period End2020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-31
Value4219000.03736000.03142000.02873000.03725000.03489000.03199000.02929000.0
Percentage of DeferredTaxLiabilitiesDeferredExpenseCapitalizedPatentCosts100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:DeferredTaxLiabilitiesOtherComprehensiveIncome

us-gaap:DeferredTaxLiabilitiesOtherComprehensiveIncome


Deferred
Period End2020-12-312019-12-31
Value24000.0327000.0
Percentage of DeferredTaxLiabilitiesOtherComprehensiveIncome100.0100.0

us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions us-gaap:AwardType

us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions

us-gaap:RestrictedStockUnitsRSU


Employee
Period End2021-06-302021-03-312020-12-312020-09-302019-12-312018-12-31
Value15178.59.22.50.7
Percentage of EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions100.0100.0100.0100.0100.0100.0

us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions us-gaap:AwardType

us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions

us-gaap:EmployeeStock


Employee
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-06-302016-03-312015-12-312014-12-31
Value0.50.70.91.11.31.31.40.10.40.20.81.01.20.1628941.10.1021760.2423050.3390.4810.4910.4180.3950.204
Percentage of EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:EmployeeStockOption


Employee
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-06-302016-03-312015-12-312014-12-312013-12-312012-12-31
Value657148535962515663644244474930333535181616107.60.8950.026
Percentage of EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions13000.010200.05433.34881.84569.24784.63650.056600.015750.032350.05350.04450.03991.730572.02790.932590.814609.710442.53763.03319.83899.52734.23725.50.00.0

us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount

us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount


Equity
Period End2021-06-302021-03-312020-12-31
Value172816
Percentage of EquitySecuritiesWithoutReadilyDeterminableFairValueAmount100.0100.0100.0

us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount us-gaap:CounterpartyName, us-gaap:StatementClassOfStock

xncr:CatabasisPharmaceuticalsInc, us-gaap:PreferredStock


Equity
Period End2021-06-30
Value1.075
Percentage of EquitySecuritiesWithoutReadilyDeterminableFairValueAmount6.3

us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount us-gaap:FairValueByFairValueHierarchyLevel

us-gaap:FairValueInputsLevel3


Equity
Period End2021-06-302021-03-312020-12-31
Value172816
Percentage of EquitySecuritiesWithoutReadilyDeterminableFairValueAmount100.0100.0100.0

us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount us-gaap:FairValueByFairValueHierarchyLevel, us-gaap:FairValueByMeasurementFrequency

us-gaap:FairValueInputsLevel3, us-gaap:FairValueMeasurementsRecurring


Equity
Period End2020-12-31
Value16
Percentage of EquitySecuritiesWithoutReadilyDeterminableFairValueAmount100.0

us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount us-gaap:FairValueByMeasurementFrequency

us-gaap:FairValueMeasurementsRecurring


Equity
Period End2020-12-31
Value16
Percentage of EquitySecuritiesWithoutReadilyDeterminableFairValueAmount100.0

us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount us-gaap:StatementClassOfStock

us-gaap:PreferredStock


Equity
Period End2021-06-302020-12-31
Value1716
Percentage of EquitySecuritiesWithoutReadilyDeterminableFairValueAmount100.0100.0

us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue us-gaap:FairValueByAssetClass, us-gaap:FairValueByFairValueHierarchyLevel

us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue

us-gaap:EquitySecurities, us-gaap:FairValueInputsLevel3


Fair
Period End2021-06-302020-12-31
Value1716
Percentage of FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue100.0100.0

us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization us-gaap:FiniteLivedIntangibleAssetsByMajorClass

us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization

us-gaap:Patents


Finite
Period End2020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-31
Value5791000.04912000.04142000.03413000.02792000.02214000.01776000.01395000.0
Percentage of FiniteLivedIntangibleAssetsAccumulatedAmortization100.0100.0100.0100.0100.0100.0100.0100.0

xncr:LicensesAndOtherIntangibleAssets


Finite
Period End2020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-31
Value1661000.01439000.01263000.01124000.0960000.0825000.0679000.0426000.0
Percentage of FiniteLivedIntangibleAssetsAccumulatedAmortization28.729.330.532.934.437.338.230.5

us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive

us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive


Finite
Period End2020-12-31
Value3208000.0
Percentage of FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive100.0

us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths

us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths


Finite
Period End2020-12-31
Value947000.0
Percentage of FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths100.0

us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive

us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive


Finite
Period End2020-12-31
Value589000.0
Percentage of FiniteLivedIntangibleAssetsAmortizationExpenseYearFive100.0

us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour

us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour


Finite
Period End2020-12-31
Value667000.0
Percentage of FiniteLivedIntangibleAssetsAmortizationExpenseYearFour100.0

us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree

us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree


Finite
Period End2020-12-31
Value829000.0
Percentage of FiniteLivedIntangibleAssetsAmortizationExpenseYearThree100.0

us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo

us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo


Finite
Period End2020-12-31
Value906000.0
Percentage of FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo100.0

us-gaap:FiniteLivedIntangibleAssetsGross us-gaap:FiniteLivedIntangibleAssetsByMajorClass

us-gaap:FiniteLivedIntangibleAssetsGross

xncr:LicensesAndOtherIntangibleAssets


Finite
Period End2020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-31
Value2.562.512.0112.0112.0112.0721.7971.917
Percentage of FiniteLivedIntangibleAssetsGross100.0100.0100.0100.0100.0100.0100.0100.0

xncr:PatentsDefiniteLife


Finite
Period End2020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-31
Value12109.328.9157.576.4885.724.834
Percentage of FiniteLivedIntangibleAssetsGross470.2422.2463.5443.3376.4313.1318.3252.2

xncr:PatentsPendingIssuance


Finite
Period End2020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-31
Value8.4327.2665.6444.364.1344.0513.6543.515
Percentage of FiniteLivedIntangibleAssetsGross329.4289.5280.7216.8205.6195.5203.3183.4

us-gaap:IntangibleAssetsGrossExcludingGoodwill

us-gaap:IntangibleAssetsGrossExcludingGoodwill


Intangible
Period End2020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-31
Value2320171514131110
Percentage of IntangibleAssetsGrossExcludingGoodwill100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:InterestReceivableCurrent

us-gaap:InterestReceivableCurrent


Interest
Period End2020-12-312019-12-31
Value1400000.02700000.0
Percentage of InterestReceivableCurrent100.0100.0

us-gaap:Investments

us-gaap:Investments


Investments
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-31
Value514559594553578585583599616506522528551578351
Percentage of Investments100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths

us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths


Lessee
Period End2021-06-302021-03-312020-12-312020-09-30
Value2093000.02269000.02429000.02647000.0
Percentage of LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths100.0100.0100.0100.0

us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear

us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear


Lessee
Period End2021-06-302021-03-312020-09-30
Value1117000.01773000.0655000.0
Percentage of LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear100.0100.0100.0

us-gaap:MarketableSecuritiesNoncurrent

us-gaap:MarketableSecuritiesNoncurrent


Marketable
Period End2020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-31
Value311.145387173120172236276299120139163190237273197778696
Percentage of MarketableSecuritiesNoncurrent100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent

us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent


Operating
Period End2021-06-302021-03-312020-12-312020-09-302019-12-31
Value4.05.55.55.55.5
Percentage of OperatingLeaseWeightedAverageDiscountRatePercent100.0100.0100.0100.0100.0

us-gaap:OperatingLossCarryforwards us-gaap:IncomeTaxAuthority

us-gaap:OperatingLossCarryforwards

us-gaap:DomesticCountry


Operating
Period End2020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-31
Value213144191104145181169
Percentage of OperatingLossCarryforwards100.0100.0100.0100.0100.0100.0100.0

us-gaap:StateAndLocalJurisdiction


Operating
Period End2020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-31
Value161921385091127134
Percentage of OperatingLossCarryforwards75.664.172.748.663.170.479.3

us-gaap:OperatingLossCarryforwards us-gaap:IncomeTaxAuthority, us-gaap:TaxPeriod

us-gaap:DomesticCountry, us-gaap:TaxYear2018


Operating
Period End2020-12-312019-12-312018-12-31
Value1457688
Percentage of OperatingLossCarryforwards68.253.046.4

us-gaap:DomesticCountry, xncr:YearsPriorTo2018


Operating
Period End2020-12-312019-12-312018-12-31
Value6868102
Percentage of OperatingLossCarryforwards31.847.053.7

us-gaap:OtherCommitment us-gaap:CounterpartyName

us-gaap:OtherCommitment

xncr:UniversityOfTexasM.d.AndersonCancerCenter


Other
Period End2020-09-30
Value10000000.0
Percentage of OtherCommitment100.0

us-gaap:OtherCommitment us-gaap:CounterpartyName, us-gaap:TypeOfArrangement

xncr:UniversityOfTexasM.d.AndersonCancerCenter, xncr:StrategicCollaborationAgreement


Other
Period End2020-08-31
Value10000000.0
Percentage of OtherCommitment0.0

us-gaap:RevenueRemainingPerformanceObligation us-gaap:CounterpartyName, us-gaap:ProductOrService, us-gaap:TypeOfArrangement

us-gaap:RevenueRemainingPerformanceObligation

xncr:Genentech, xncr:ResearchActivity, xncr:CollaborationAndLicenseAgreement


Revenue
Period End2020-12-312019-03-312019-02-28
Value8.38.38.3
Percentage of RevenueRemainingPerformanceObligation100.0100.0100.0

us-gaap:RevenueRemainingPerformanceObligation us-gaap:CounterpartyName, us-gaap:TypeOfArrangement

xncr:AmgenInc, xncr:ResearchAndLicenseAgreement


Revenue
Period End2021-06-302019-12-312015-09-30
Value0.96045
Percentage of RevenueRemainingPerformanceObligation0.00.00.0

xncr:JanssenBiotechInc, xncr:CollaborationAndLicenseAgreement


Revenue
Period End2020-11-30
Value50
Percentage of RevenueRemainingPerformanceObligation0.0

xncr:MiragenViridian, xncr:TechnologyLicenseAgreement


Revenue
Period End2020-12-31
Value6.0
Percentage of RevenueRemainingPerformanceObligation72.3

xncr:OmerosCorporation, xncr:TechnologyLicenseAgreement


Revenue
Period End2020-08-31
Value5.0
Percentage of RevenueRemainingPerformanceObligation0.0

xncr:PrivateBiotechCompany, xncr:LicenseAgreement


Revenue
Period End2020-11-30
Value16
Percentage of RevenueRemainingPerformanceObligation0.0

xncr:ZenasBioPharmaLimited, xncr:LicenseAgreement


Revenue
Period End2020-11-30
Value16
Percentage of RevenueRemainingPerformanceObligation0.0

us-gaap:RevenueRemainingPerformanceObligation us-gaap:CounterpartyName, us-gaap:TypeOfArrangement, xncr:CollaborationAndLicensingPrograms

xncr:MiragenViridian, xncr:TechnologyLicenseAgreement, xncr:XtendFcTechnologyLicenseAgreement


Revenue
Period End2020-12-31
Value6.0
Percentage of RevenueRemainingPerformanceObligation72.3

xncr:OmerosCorporation, xncr:TechnologyLicenseAgreement, xncr:InitialOptionExercises


Revenue
Period End2020-08-31
Value3.0
Percentage of RevenueRemainingPerformanceObligation0.0

xncr:OmerosCorporation, xncr:TechnologyLicenseAgreement, xncr:XtendFcTechnologyLicenseAgreement


Revenue
Period End2020-08-31
Value2.0
Percentage of RevenueRemainingPerformanceObligation0.0

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue us-gaap:AwardType

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue

us-gaap:RestrictedStockUnitsRSU


Share
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-31
Value38.7938.5633.0432.6532.3732.7634.6633.0532.6932.7327.64
Percentage of ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber us-gaap:AwardType

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber

us-gaap:EmployeeStockOption


Share
Period End2021-06-302021-03-312020-09-30
Value5265800.04963600.04796500.0
Percentage of ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber100.0100.0100.0

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice us-gaap:AwardType

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice

us-gaap:EmployeeStockOption


Share
Period End2021-06-302021-03-312020-09-30
Value23.3722.7320.9
Percentage of ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice100.0100.0100.0

xncr:EmployeeAndNonEmployeeStockOption


Share
Period End2020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-31
Value21.7517.7915.1211.068.873.991.010.590.59
Percentage of ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice0.00.00.00.00.00.00.00.00.0

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue us-gaap:AwardType

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue

us-gaap:EmployeeStockOption


Share
Period End2021-06-302021-03-312020-12-312020-09-30
Value65125134107
Percentage of ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue100.0100.0100.0100.0

xncr:EmployeeAndNonEmployeeStockOption


Share
Period End2020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-31
Value13479993558213013
Percentage of ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue100.00.00.00.00.00.00.00.0

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue us-gaap:AwardType

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue

xncr:EmployeeAndNonEmployeeStockOption


Share
Period End2020-12-31
Value134
Percentage of ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue100.0

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice us-gaap:AwardType

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice

xncr:EmployeeAndNonEmployeeStockOption


Share
Period End2020-12-31
Value26.23
Percentage of ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice100.0

us-gaap:SharePrice us-gaap:AwardType

us-gaap:SharePrice

us-gaap:EmployeeStockOption


Share
Period End2021-06-302021-03-312020-09-302014-09-302014-06-30
Value34.4943.0638.799.3111.62
Percentage of SharePrice100.0100.0100.0100.0100.0

us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 us-gaap:AwardType

us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1

us-gaap:EmployeeStockOption


Sharebased
Period End2021-06-302021-03-312020-09-30
Value6110086
Percentage of SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1100.0100.0100.0

xncr:EmployeeAndNonEmployeeStockOption


Sharebased
Period End2020-12-31
Value102
Percentage of SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue10.0

us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1

us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1


Sharebased
Period End2020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-31
Value21.7517.7915.1211.068.873.991.01
Percentage of SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1100.0100.0100.0100.0100.0100.0100.0

us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1 us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRange

xncr:SharesAuthorizedUnderStockOptionPlansExercisePriceRangeFive


Sharebased
Period End2020-12-312019-12-312018-12-31
Value37.5139.8538.93
Percentage of SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1172.5224.0257.5

xncr:SharesAuthorizedUnderStockOptionPlansExercisePriceRangeFour


Sharebased
Period End2020-12-312019-12-312018-12-312017-12-312016-12-312015-12-31
Value30.1227.6423.0824.1316.216.52
Percentage of SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1138.5155.4152.6218.2182.6414.0

xncr:SharesAuthorizedUnderStockOptionPlansExercisePriceRangeOne


Sharebased
Period End2020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-31
Value4.293.493.633.172.661.380.99
Percentage of SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice119.719.624.028.730.034.698.0

xncr:SharesAuthorizedUnderStockOptionPlansExercisePriceRangeThree


Sharebased
Period End2020-12-312019-12-312018-12-312017-12-312016-12-312015-12-31
Value22.6720.6216.3515.6811.3111.11
Percentage of SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1104.2115.9108.1141.8127.5278.4

xncr:SharesAuthorizedUnderStockOptionPlansExercisePriceRangeTwo


Sharebased
Period End2020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-31
Value13.112.1911.9711.645.557.095.5
Percentage of SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice160.268.579.2105.262.6177.7544.6

us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1

us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1


Sharebased
Period End2020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-31
Value26.2324.0319.7115.3211.958.55.12
Percentage of SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1100.0100.0100.0100.0100.0100.0100.0

us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1 us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRange

xncr:SharesAuthorizedUnderStockOptionPlansExercisePriceRangeFive


Sharebased
Period End2020-12-312019-12-312018-12-312016-12-31
Value37.6337.2239.2625.3
Percentage of SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1143.5154.9199.2211.7

xncr:SharesAuthorizedUnderStockOptionPlansExercisePriceRangeFour


Sharebased
Period End2020-12-312019-12-312018-12-312017-12-312016-12-312015-12-31
Value31.831.1823.9223.016.416.0
Percentage of SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1121.2129.8121.4150.1137.2188.2

xncr:SharesAuthorizedUnderStockOptionPlansExercisePriceRangeOne


Sharebased
Period End2020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-31
Value4.293.493.633.172.831.871.63
Percentage of SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance116.414.518.420.723.722.031.8

xncr:SharesAuthorizedUnderStockOptionPlansExercisePriceRangeThree


Sharebased
Period End2020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-31
Value22.7521.3717.015.812.111.211.1
Percentage of SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance186.788.986.3103.1101.3131.8216.8

xncr:SharesAuthorizedUnderStockOptionPlansExercisePriceRangeTwo


Sharebased
Period End2020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-31
Value13.112.2112.111.875.977.647.73
Percentage of SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance149.950.861.477.550.089.9151.0

us-gaap:TaxCreditCarryforwardAmount us-gaap:IncomeTaxAuthority

us-gaap:TaxCreditCarryforwardAmount

us-gaap:DomesticCountry


Tax
Period End2020-12-312019-12-312018-12-312017-12-312016-12-312015-12-31
Value26191410.06.43.9
Percentage of TaxCreditCarryforwardAmount100.0100.0100.0100.0100.0100.0

us-gaap:StateAndLocalJurisdiction


Tax
Period End2020-12-312019-12-312018-12-312017-12-312016-12-312015-12-31
Value14118.26.65.24.2
Percentage of TaxCreditCarryforwardAmount53.655.855.066.081.2107.7

xncr:AnnualFundingAmount us-gaap:CounterpartyName, us-gaap:TypeOfArrangement

xncr:AnnualFundingAmount

xncr:UniversityOfTexasM.d.AndersonCancerCenter, xncr:StrategicCollaborationAgreement


Annual
Period End2020-08-31
Value2000000.0
Percentage of AnnualFundingAmount100.0

xncr:CashAndCashEquivalentsAndMarketableSecuritiesAmortizedCost

xncr:CashAndCashEquivalentsAndMarketableSecuritiesAmortizedCost


Cash
Period End2021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-03-312018-12-312018-03-31
Value514559594553576584581598506523580
Percentage of CashAndCashEquivalentsAndMarketableSecuritiesAmortizedCost100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

xncr:CollaborativeArrangementReceivablePayableRelatedToCostSharingDevelopmentActivities us-gaap:CounterpartyName, us-gaap:ProductOrService, us-gaap:TypeOfArrangement

xncr:CollaborativeArrangementReceivablePayableRelatedToCostSharingDevelopmentActivities

xncr:Genentech, xncr:Xmab24306Product, xncr:CollaborationAndLicenseAgreement


Collaborative
Period End2021-06-302021-03-312020-09-30
Value-2300000.0-2900000.0-1200000.0
Percentage of CollaborativeArrangementReceivablePayableRelatedToCostSharingDevelopmentActivities100.0100.0100.0

xncr:Novartis, xncr:Development, xncr:CollaborationAndLicenseAgreement


Collaborative
Period End2021-06-30
Value800000.0
Percentage of CollaborativeArrangementReceivablePayableRelatedToCostSharingDevelopmentActivities-34.8

xncr:Novartis, xncr:Milestone, xncr:CollaborationAndLicenseAgreement


Collaborative
Period End2021-06-30
Value1000000.0
Percentage of CollaborativeArrangementReceivablePayableRelatedToCostSharingDevelopmentActivities-43.5

xncr:CollaborativeArrangementReceivablePayableRelatedToCostSharingDevelopmentActivities us-gaap:CounterpartyName, us-gaap:TypeOfArrangement

xncr:AlexionPharmaceuticalsInc, xncr:OptionAndLicenseAgreement


Collaborative
Period End2020-09-30
Value8100000.0
Percentage of CollaborativeArrangementReceivablePayableRelatedToCostSharingDevelopmentActivities-675.0

xncr:AtrecaInc., xncr:CollaborationAndLicenseAgreement


Collaborative
Period End2020-09-30
Value-100000.0
Percentage of CollaborativeArrangementReceivablePayableRelatedToCostSharingDevelopmentActivities8.3

xncr:Genentech, xncr:CollaborationAndLicenseAgreement


Collaborative
Period End2020-12-31
Value-3200000.0
Percentage of CollaborativeArrangementReceivablePayableRelatedToCostSharingDevelopmentActivities0.0

xncr:Novartis, xncr:CollaborationAndLicenseAgreement


Collaborative
Period End2021-03-312020-09-30
Value900000.01100000.0
Percentage of CollaborativeArrangementReceivablePayableRelatedToCostSharingDevelopmentActivities-31.0-91.7

xncr:DeferredTaxLiabilitiesCapitalizedLegalCosts

xncr:DeferredTaxLiabilitiesCapitalizedLegalCosts


Deferred
Period End2020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-31
Value21000.026000.031000.036000.058000.064000.071000.0119000.0
Percentage of DeferredTaxLiabilitiesCapitalizedLegalCosts100.0100.0100.0100.0100.0100.0100.0100.0

xncr:DeferredTaxLiabilitiesEquityInvestment

xncr:DeferredTaxLiabilitiesEquityInvestment


Deferred
Period End2020-12-31
Value4497000.0
Percentage of DeferredTaxLiabilitiesEquityInvestment100.0

xncr:DeferredTaxLiabilitiesLicenseCosts

xncr:DeferredTaxLiabilitiesLicenseCosts


Deferred
Period End2020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-31
Value194000.0229000.0125000.0142000.0261000.0339000.0317000.0406000.0
Percentage of DeferredTaxLiabilitiesLicenseCosts100.0100.0100.0100.0100.0100.0100.0100.0

xncr:EquitySecuritiesCurrent

xncr:EquitySecuritiesCurrent


Equity
Period End2021-03-312020-12-31
Value6136000.05303000.0
Percentage of EquitySecuritiesCurrent100.0100.0

xncr:EquitySecuritiesNoncurrent

xncr:EquitySecuritiesNoncurrent


Equity
Period End2021-06-302021-03-312020-12-31
Value172816
Percentage of EquitySecuritiesNoncurrent100.0100.0100.0

xncr:PercentageOfCoDetailingActivities us-gaap:CounterpartyName, us-gaap:TypeOfArrangement

xncr:PercentageOfCoDetailingActivities

xncr:JanssenBiotechInc, xncr:CollaborationAndLicenseAgreement


Percentage
Period End2020-11-30
Value30.0
Percentage of PercentageOfCoDetailingActivities100.0

xncr:PercentageOfFundingForDevelopmentCosts us-gaap:CounterpartyName, us-gaap:TypeOfArrangement

xncr:PercentageOfFundingForDevelopmentCosts

xncr:JanssenBiotechInc, xncr:CollaborationAndLicenseAgreement


Percentage
Period End2020-11-30
Value20.0
Percentage of PercentageOfFundingForDevelopmentCosts100.0

xncr:ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfCompensationWithheldToPurchaseSharesAtDiscount us-gaap:Range, us-gaap:AwardType

xncr:ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfCompensationWithheldToPurchaseSharesAtDiscount

srt:Maximum, us-gaap:EmployeeStock


Share
Period End2020-12-312019-12-312018-12-31
Value15.00.150.15
Percentage of ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfCompensationWithheldToPurchaseSharesAtDiscount100.0100.0100.0

srt:Minimum, us-gaap:EmployeeStock


Share
Period End2020-12-312019-12-312018-12-31
Value1.00.010.01
Percentage of ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfCompensationWithheldToPurchaseSharesAtDiscount6.76.76.7

Line plots across dimensions of each concept


TTM Greenblatt ROC
_
(None,)
T T M  Greenblatt  R O C_
us-gaap:AllocatedShareBasedCompensationExpense
us-gaap:IncomeStatementLocation
(None,)
Allocated Share Based Compensation Expenseus-gaap: Income Statement Location
us-gaap:AllocatedShareBasedCompensationExpense
us-gaap:AwardType
(None,)
Allocated Share Based Compensation Expenseus-gaap: Award Type
us-gaap:ComprehensiveIncomeNetOfTax
us-gaap:StatementEquityComponents
(None,)
Comprehensive Income Net Of Taxus-gaap: Statement Equity Components
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
us-gaap:ProductOrService
(None,)
Revenue From Contract With Customer Excluding Assessed Taxus-gaap: Product Or Service
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
us-gaap:CounterpartyName
(None,)
Revenue From Contract With Customer Excluding Assessed Taxus-gaap: Counterparty Name
us-gaap:StockholdersEquity
us-gaap:StatementEquityComponents
(None,)
Stockholders Equityus-gaap: Statement Equity Components
us-gaap:CashAndCashEquivalentsAtCarryingValue
us-gaap:InvestmentType
(None,)
Cash And Cash Equivalents At Carrying Valueus-gaap: Investment Type
us-gaap:PropertyPlantAndEquipmentGross
us-gaap:PropertyPlantAndEquipmentByType
(None,)
Property Plant And Equipment Grossus-gaap: Property Plant And Equipment By Type
us-gaap:StockholdersEquity
us-gaap:StatementEquityComponents
(None,)
Stockholders Equityus-gaap: Statement Equity Components
us-gaap:ShareBasedCompensation
us-gaap:IncomeStatementLocation
(None,)
Share Based Compensationus-gaap: Income Statement Location
us-gaap:ShareBasedCompensation
us-gaap:AwardType
(None,)
Share Based Compensationus-gaap: Award Type